1304-5 | D Ab [Titer] in Serum or Plasma | D Ab |
52115-3 | D Ab [Presence] in Serum or Plasma by Antihuman globulin | D Ab |
973-8 | D Ab [Presence] in Serum or Plasma from Blood product unit | D Ab |
974-6 | D Ab [Presence] in Serum or Plasma from donor | D Ab |
975-3 | D Ab [Presence] in Serum or Plasma | D Ab |
1305-2 | D Ag [Presence] in Blood | D Ag |
976-1 | D Ag [Presence] on Red Blood Cells from Blood product unit | D Ag |
977-9 | D Ag [Presence] on Red Blood Cells from donor | D Ag |
978-7 | D Ag [Presence] on Red Blood Cells | D Ag |
979-5 | Di^a Ab [Presence] in Serum or Plasma from Blood product unit | D little i super little a Ab |
980-3 | Di^a Ab [Presence] in Serum or Plasma from donor | D little i super little a Ab |
981-1 | Di^a Ab [Presence] in Serum or Plasma | D little i super little a Ab |
982-9 | Di^a Ag [Presence] on Red Blood Cells from Blood product unit | D little i super little a Ag |
983-7 | Di^a Ag [Presence] on Red Blood Cells from donor | D little i super little a Ag |
984-5 | Di^a Ag [Presence] on Red Blood Cells | D little i super little a Ag |
985-2 | Di^b Ab [Presence] in Serum or Plasma from Blood product unit | D little i super little b Ab |
986-0 | Di^b Ab [Presence] in Serum or Plasma from donor | D little i super little b Ab |
987-8 | Di^b Ab [Presence] in Serum or Plasma | D little i super little b Ab |
988-6 | Di^b Ag [Presence] on Red Blood Cells from Blood product unit | D little i super little b Ag |
989-4 | Di^b Ag [Presence] on Red Blood Cells from donor | D little i super little b Ag |
990-2 | Di^b Ag [Presence] on Red Blood Cells | D little i super little b Ag |
991-0 | Do^a Ab [Presence] in Serum or Plasma from Blood product unit | D little o super little a Ab |
992-8 | Do^a Ab [Presence] in Serum or Plasma from donor | D little o super little a Ab |
993-6 | Do^a Ab [Presence] in Serum or Plasma | D little o super little a Ab |
994-4 | Do^a Ag [Presence] on Red Blood Cells from Blood product unit | D little o super little a Ag |
995-1 | Do^a Ag [Presence] on Red Blood Cells from donor | D little o super little a Ag |
996-9 | Do^a Ag [Presence] on Red Blood Cells | D little o super little a Ag |
967-0 | None | D little u Ab |
968-8 | None | D little u Ab |
969-6 | None | D little u Ab |
970-4 | Du Ag [Presence] on Red Blood Cells from Blood product unit | D little u Ag |
971-2 | Du Ag [Presence] on Red Blood Cells from donor | D little u Ag |
972-0 | Du Ag [Presence] on Red Blood Cells | D little u Ag |
1306-0 | D NOS Ab [Presence] in Serum or Plasma | D NOS Ab |
1307-8 | D NOS Ab [Presence] in Serum or Plasma from Blood product unit | D NOS Ab |
1308-6 | D NOS Ab [Presence] in Serum or Plasma from donor | D NOS Ab |
1309-4 | None | D NOS Ab |
1310-2 | D NOS Ag [Presence] on Red Blood Cells from Blood product unit | D NOS Ag |
1311-0 | D NOS Ag [Presence] on Red Blood Cells from donor | D NOS Ag |
1312-8 | D NOS Ag [Presence] on Red Blood Cells | D NOS Ag |
17997-8 | None | D-E excursion |
14045-9 | D-Lactate [Molecules/volume] in Serum or Plasma | D-lactate |
14046-7 | D-Lactate [Molecules/volume] in Urine | D-lactate |
44314-3 | D-Lactate/Creatinine [Molecular ratio] in Urine | D-lactate/Creatinine |
25899-6 | D-Lactate [Molecules/volume] in Serum or Plasma --1st specimen post excercise | D-Lactate^1st specimen post exercise |
25900-2 | D-Lactate [Molecules/volume] in Serum or Plasma --2nd specimen post excercise | D-Lactate^2nd specimen post exercise |
25901-0 | D-Lactate [Molecules/volume] in Serum or Plasma --3rd specimen post excercise | D-Lactate^3rd specimen post exercise |
25902-8 | D-Lactate [Molecules/volume] in Serum or Plasma --4th specimen post excercise | D-Lactate^4th specimen post exercise |
25903-6 | D-Lactate [Molecules/volume] in Serum or Plasma --5th specimen post excercise | D-Lactate^5th specimen post exercise |
25904-4 | D-Lactate [Molecules/volume] in Serum or Plasma --6th specimen post excercise | D-Lactate^6th specimen post exercise |
25905-1 | D-Lactate [Molecules/volume] in Serum or Plasma --Pre excercise | D-lactate^pre exercise |
13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma | D-pseudoephedrine |
7791-7 | Dacrocytes [Presence] in Blood by Light microscopy | Dacryocytes |
19735-0 | None | Dactylis glomerata Ab.IgE |
6195-2 | Cocksfoot IgE Ab [Units/volume] in Serum | Dactylis glomerata Ab.IgE |
15746-1 | Cocksfoot IgE Ab RAST class in Serum | Dactylis glomerata Ab.IgE.RAST class |
25380-7 | None | Dactylis glomerata Ab.IgE.RAST class |
7365-0 | Cocksfoot IgG Ab [Units/volume] in Serum | Dactylis glomerata Ab.IgG |
7366-8 | Cocksfoot triggered histamine release [Units/volume] in Blood | Dactylis glomerata basophil bound Ab |
48263-8 | Cocksfoot triggered leukotriene release [Mass/volume] by Leukocytes | Dactylis glomerata leukotriene release |
7273-6 | Dahlia IgE Ab [Units/volume] in Serum | Dahlia sp Ab.IgE |
45449-6 | None | Daily animal companion &or presence |
45774-7 | None | Daily cleaning of teeth or dentures or mouth care by resident or staff |
45446-2 | None | Daily contact with relatives &or close friends |
41688-3 | Dalbavancin [Susceptibility] by Disk diffusion (KB) | Dalbavancin |
41689-1 | Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dalbavancin |
41690-9 | Dalbavancin [Susceptibility] by Gradient strip (E-test) | Dalbavancin |
41734-5 | Dalbavancin [Susceptibility] | Dalbavancin |
9746-9 | Dantrolene [Mass/volume] in Serum or Plasma | Dantrolene |
3527-9 | Dantron [Mass/volume] in Urine | Dantron |
4208-5 | Dantron [Mass] of Dose | Dantron |
42665-0 | Dantron [Mass/mass] in Stool | Dantron |
10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum | Daphnia Ab.IgE |
15677-8 | Daphnia (fish feed) IgE Ab RAST class in Serum | Daphnia Ab.IgE.RAST class |
51698-9 | Dapsone [Susceptibility] | Dapsone |
9747-7 | Dapsone [Mass/volume] in Serum or Plasma | Dapsone |
35787-1 | Daptomycin [Susceptibility] by Disk diffusion (KB) | Daptomycin |
35788-9 | Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Daptomycin |
35789-7 | Daptomycin [Susceptibility] | Daptomycin |
41691-7 | Daptomycin [Susceptibility] by Gradient strip (E-test) | Daptomycin |
49666-1 | Darunavir [Susceptibility] by Phenotype method | Darunavir |
49630-7 | Darunavir+Ritonavir [Susceptibility] by Genotype method | Darunavir+Ritonavir |
35524-8 | None | Data handling and record keeping section |
46697-9 | None | Date |
45285-4 | Date & Time of Dose | Date & Time |
21932-9 | None | Date 1st cancer Rx (any).COC |
21931-1 | None | Date 1st cancer Rx (any).SEERS |
21927-9 | None | Date 1st chemotherapy treatment |
21928-7 | None | Date 1st hormone treatment |
21929-5 | None | Date 1st immunotherapy treatment |
39808-1 | None | Date 1st most definitive surgery Rx for |
21930-3 | None | Date 1st other treatment |
21919-6 | None | Date 1st positive Bx |
21926-1 | None | Date 1st radiation treatment |
21925-3 | None | Date 1st surgery treatment |
39809-9 | None | Date 1st systemic treatment |
30953-4 | None | Date and time of onset of vaccination adverse event |
49542-4 | Date and time of pheresis procedure | Date and time of pheresis procedure |
30952-6 | None | Date and time of vaccination |
46501-3 | None | Date assessment information completed |
18646-0 | Psychiatric rehabilitation treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
27492-8 | Alcohol-substance abuse rehabilitation treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
27540-4 | Cardiac rehabilitation treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
27562-8 | Skilled nursing treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
27613-9 | Occupational therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
27676-6 | Physical therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
27715-2 | Respiratory therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
27766-5 | Medical social services treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
29172-4 | Speech therapy treatment plan, date attending MD referred patient for treatment | Date attending MD referred patient for |
18647-8 | Psychiatric rehabilitation treatment plan, date attending MD signed | Date attending MD signed |
27493-6 | Alcohol-substance abuse rehabilitation treatment plan, date responsible attending md signed | Date attending MD signed |
27541-2 | Cardiac rehabilitation treatment plan, date attending MD signed | Date attending MD signed |
27563-6 | Skilled nursing treatment plan, date attending MD signed | Date attending MD signed |
27614-7 | Occupational therapy treatment plan, date attending MD signed | Date attending MD signed |
27677-4 | Physical therapy treatment plan, date attending MD signed | Date attending MD signed |
27716-0 | Respiratory therapy treatment plan, date attending MD signed | Date attending MD signed |
27767-3 | Medical social services treatment plan, date attending MD signed | Date attending MD signed |
29173-2 | Speech therapy treatment plan, date attending MD signed | Date attending MD signed |
52156-7 | None | Date attending MD signed |
45427-2 | None | Date background information form completed |
52116-1 | Date blood unit received | Date blood product unit received |
22005-3 | None | Date case completed |
22006-1 | None | Date case last changed |
22007-9 | None | Date case report exported |
22009-5 | None | Date case report loaded |
22008-7 | None | Date case report received |
47241-5 | None | Date determined medically eligible and ready to start HIV Rx |
47240-7 | None | Date determined medically eligible to start HIV Rx |
45257-3 | None | Date dropped from HIV Rx |
45234-2 | None | Date eligible and selected to start HIV Rx |
29191-4 | Speech therapy treatment plan, plan end date | Date end |
21854-5 | None | Date first Dx |
30947-6 | None | Date form completed |
46636-7 | None | Date form completed |
21975-8 | None | Date last contact |
29742-4 | Date last dose | Date last dose |
8665-2 | None | Date last menstrual period |
21863-6 | None | Date last screened |
45237-5 | None | Date lost to HIV Rx follow-up |
45238-3 | None | Date lost to HIV Rx therapy |
45354-8 | None | Date next dose |
39161-5 | None | Date next screen visit |
21933-7 | None | Date non cancer directed surgery Rx as part of 1st cancer |
45353-0 | Date of analysis of unspecified specimen | Date of analysis |
53665-6 | None | Date of best overall gestational age estimate |
42029-9 | None | Date of conclusive diagnosis |
31211-6 | None | Date of death |
53719-1 | None | Date of death - Canada |
42031-5 | None | Date of diagnosis of multiple tumors |
50786-3 | None | Date of entry |
21870-1 | None | Date of inpatient admission |
21871-9 | None | Date of inpatient discharge |
45453-8 | None | Date of last day of MDS observation period |
46581-5 | None | Date of last home visit |
18654-4 | Psychiatric rehabilitation treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
27501-6 | Alcohol-substance abuse rehabilitation treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
27548-7 | Cardiac rehabilitation treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
27570-1 | Skilled nursing treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
27621-2 | Occupational therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
27684-0 | Physical therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
27723-6 | Respiratory therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
27774-9 | Medical social services treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
29180-7 | Speech therapy treatment plan, date of last plan of treatment certification | Date of last plan of treatment certification |
18670-0 | None | Date of next planned rehabilitation treatment |
30907-0 | Alcohol-substance abuse treatment plan, date range (from/through) of next planned treatment (composite) | Date of next planned rehabilitation treatment |
31035-9 | None | Date of other vaccinations given within 4 weeks prior to the date of vaccine causing adverse event |
53663-1 | None | Date of prior gestational age estimate |
45455-3 | None | Date of reentry to facility |
45351-4 | Date of skin test | Date of skin test |
42117-2 | None | Date of surgical discharge |
45376-1 | Date of transfusion reaction | Date of transfusion reaction |
52584-0 | None | Date of ulcer measurement |
30944-3 | None | Date of vaccination temporary contraindication &or precaution expiration |
30573-0 | None | Date of wound healing |
45235-9 | None | Date original clinic HIV Rx start |
52082-5 | Alcohol-substance abuse rehabilitation treatment plan, referral information - date patient referred for treatment | Date patient referred for treatment |
52153-4 | None | Date patient referred for treatment |
52195-5 | None | Date patient referred for treatment |
52222-7 | None | Date patient referred for treatment |
52269-8 | None | Date patient referred for treatment |
52277-1 | None | Date patient referred for treatment |
52308-4 | None | Date patient referred for treatment |
52339-9 | None | Date patient referred for treatment |
52362-1 | None | Date patient referred for treatment |
52389-4 | None | Date patient referred for treatment |
39255-5 | None | Date previous screen visit |
42120-6 | None | Date radiation ended |
18642-9 | Psychiatric rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
27490-2 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
27536-2 | Cardiac rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
27560-2 | Skilled nursing treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
27611-3 | Occupational therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
27674-1 | Physical therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
27713-7 | Respiratory therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
27764-0 | Medical social services treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
29203-7 | Speech therapy treatment plan, date range (from/through) of hospitalization leading to treatment (composite) | Date range |
52076-7 | Alcohol-substance abuse rehabilitation treatment plan, date range of treatment | Date range |
52077-5 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) of hospitalization leading to treatment | Date range |
52140-1 | None | Date range |
52147-6 | None | Date range |
52189-8 | None | Date range |
52190-6 | None | Date range |
52216-9 | None | Date range |
52217-7 | None | Date range |
52243-3 | None | Date range |
52271-4 | None | Date range |
52272-2 | None | Date range |
52301-9 | None | Date range |
52303-5 | None | Date range |
52333-2 | None | Date range |
52334-0 | None | Date range |
52356-3 | None | Date range |
52357-1 | None | Date range |
52383-7 | None | Date range |
52384-5 | None | Date range |
52413-2 | None | Date range |
18639-5 | Psychiatric rehabilitation treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
27487-8 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
27533-9 | Cardiac rehabilitation treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
27557-8 | Skilled nursing treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
27608-9 | Occupational therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
27671-7 | Physical therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
27710-3 | Respiratory therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
27761-6 | Medical social services treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
29170-8 | Speech therapy treatment plan, date range (from/through) described by plan (composite) | Date range (from_through) described by plan |
52088-2 | Alcohol-substance abuse rehabilitation treatment plan, date range certifying the plan of care | Date range certifying the plan of care |
52167-4 | None | Date range certifying the plan of care |
52200-3 | None | Date range certifying the plan of care |
52227-6 | None | Date range certifying the plan of care |
52251-6 | None | Date range certifying the plan of care |
52282-1 | None | Date range certifying the plan of care |
52316-7 | None | Date range certifying the plan of care |
52344-9 | None | Date range certifying the plan of care |
52367-0 | None | Date range certifying the plan of care |
52394-4 | None | Date range certifying the plan of care |
52106-2 | Alcohol-substance abuse rehabilitation treatment plan, date range (from/through) of next planned treatment | Date range of next planned treatment |
30976-5 | None | Date received |
49548-1 | Date reference lab test sent | Date reference lab test sent |
18648-6 | Psychiatric rehabilitation treatment plan, date rehab professional signed | Date rehabilitation professional signed |
27494-4 | Alcohol-substance abuse rehabilitation treatment plan, date rehabilitation professional signed | Date rehabilitation professional signed |
27542-0 | Cardiac rehabilitation treatment plan, date cardiac rehabilitation professional signed | Date rehabilitation professional signed |
27564-4 | Skilled nursing treatment plan, date skilled nursing professional signed | Date rehabilitation professional signed |
27615-4 | Occupational therapy treatment plan, date occupational therapy professional signed | Date rehabilitation professional signed |
27678-2 | Physical therapy treatment plan, date physical therapy professional signed | Date rehabilitation professional signed |
27717-8 | Respiratory therapy treatment plan, date respiratory therapy professional signed | Date rehabilitation professional signed |
27768-1 | Medical social services treatment plan, date medical social services professional signed | Date rehabilitation professional signed |
29175-7 | Speech therapy treatment plan, date speech therapy professional signed | Date rehabilitation professional signed |
52159-1 | None | Date rehabilitation professional signed |
45355-5 | Date RhoGam given | Date RhoGam given |
45352-2 | Date skin test interpreted | Date skin test interpreted |
29164-1 | Speech therapy treatment plan, start date | Date start |
42781-5 | None | Date surgery |
45348-0 | Date tick acquired | Date tick acquired |
45347-2 | Date tick attached | Date tick attached |
45346-4 | Date tick removed | Date tick removed |
22010-3 | None | Date tumor record available |
34970-4 | Ultrasoiund date | Date ultrasound |
30980-7 | None | Date vaccine due |
29769-7 | None | Date vaccine information statement presented |
29768-9 | None | Date vaccine information statement published |
18641-1 | Rehabilitation treatment plan, plan end date | Date.end |
27489-4 | Alcohol-substance abuse rehabilitation treatment plan, plan end date | Date.end |
27535-4 | Cardiac rehabilitation treatment plan, plan end date | Date.end |
27559-4 | Skilled nursing treatment plan, plan end date | Date.end |
27610-5 | Occupational therapy treatment plan, plan end date | Date.end |
27673-3 | Physical therapy treatment plan, plan end date | Date.end |
27712-9 | Respiratory therapy treatment plan, plan end date | Date.end |
27763-2 | Medical social services treatment plan, plan end date | Date.end |
18627-0 | Psychiatric rehabilitation treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
27471-2 | Skilled nursing treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
27484-5 | Cardiac rehabilitation treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
27598-2 | Occupational therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
27661-8 | Physical therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
27700-4 | Respiratory therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
27751-7 | Medical social services treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
27801-0 | Alcohol-substance abuse rehabilitation treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
29163-3 | Speech therapy treatment plan, date onset or exacerbation of primary diagnosis | Date.onset or exacerbation |
52139-3 | None | Date.onset or exacerbation |
18628-8 | Psychiatric rehabilitation treatment plan, start date | Date.start |
27472-0 | Skilled nursing treatment plan, start date | Date.start |
27475-3 | Alcohol-substance abuse rehabilitation treatment plan, start date | Date.start |
27485-2 | Cardiac rehabilitation treatment plan, start date | Date.start |
27599-0 | Occupational therapy treatment plan, start date | Date.start |
27662-6 | Physical therapy treatment plan, start date | Date.start |
27701-2 | Respiratory therapy treatment plan, start date | Date.start |
27752-5 | Medical social services treatment plan, start date | Date.start |
30946-8 | None | Date.vaccination contraindication &or precaution effective |
42900-1 | Carrot IgE Ab [Ratio] in Serum | Daucus carota Ab.IgE |
6061-6 | Carrot IgE Ab [Units/volume] in Serum | Daucus carota Ab.IgE |
15605-9 | Carrot IgE Ab RAST class in Serum | Daucus carota Ab.IgE.RAST class |
7180-3 | Carrot IgG Ab [Units/volume] in Serum | Daucus carota Ab.IgG |
21145-8 | Carrot IgG Ab RAST class in Serum | Daucus carota Ab.IgG.RAST class |
7181-1 | Carrot triggered histamine release [Units/volume] in Blood | Daucus carota basophil bound Ab |
48210-9 | Carrot triggered leukotriene release [Mass/volume] by Leukocytes | Daucus carota leukotriene release |
28377-0 | None | Day sweats |
46058-4 | None | Days received the following medication |
47027-8 | DBA44 Ag [Presence] in Tissue by Immune stain | DBA44 Ag |
1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | DBG Ab |
1001-7 | DBG Ab [Presence] in Serum or Plasma from donor | DBG Ab |
1002-5 | DBG Ab [Presence] in Serum or Plasma | DBG Ab |
997-7 | DBG Ag [Presence] on Red Blood Cells from Blood product unit | DBG Ag |
998-5 | DBG Ag [Presence] on Red Blood Cells from donor | DBG Ag |
999-3 | DBG Ag [Presence] on Red Blood Cells | DBG Ag |
44673-2 | None | DCIS.uninvolved margin distance.closest |
44675-7 | None | DCIS.uninvolved margin.closest |
48969-0 | DCX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DCX gene mutation analysis |
22019-4 | None | Death certificate number |
42672-6 | Debris [Presence] in Semen | Debris |
45769-7 | None | Debris - soft, easily movable substances - present in mouth prior to going to bed at night |
13726-5 | Decadienediate/Creatinine [Mass ratio] in Urine | Decadienediate/Creatinine |
25093-6 | Decadienediate/Creatinine [Molecular ratio] in Urine | Decadienediate/Creatinine |
53180-6 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Blood dot (filter paper) | Decadienoylcarnitine (C10:2) |
53459-4 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Amniotic Fluid | Decadienoylcarnitine (C10:2) |
53464-4 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Cerebral spinal fluid | Decadienoylcarnitine (C10:2) |
53471-9 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Serum or Plasma | Decadienoylcarnitine (C10:2) |
53492-5 | Decadienoylcarnitine (C10:2) [Molecules/volume] in Urine | Decadienoylcarnitine (C10:2) |
53508-8 | Decadienoylcarnitine (C10:2) [Molecular ratio] in Urine | Decadienoylcarnitine (C10:2) |
35146-0 | Decanoate (C10:0) [Molecules/volume] in Serum or Plasma | Decanoate |
47613-5 | Decanoate (C10:0)/Creatinine [Molecular ratio] in Urine | Decanoate/Creatinine |
18452-3 | Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma | Decanoylcarnitine (C10) |
30327-1 | Decanoylcarnitine (C10) [Molecules/volume] in Serum or Plasma | Decanoylcarnitine (C10) |
45197-1 | Decanoylcarnitine (C10) [Molecules/volume] in Blood dot (filter paper) | Decanoylcarnitine (C10) |
53056-8 | Decanoylcarnitine (C10) [Molecules/volume] in Amniotic Fluid | Decanoylcarnitine (C10) |
53075-8 | Decanoylcarnitine (C10) [Molecules/volume] in Cerebral spinal fluid | Decanoylcarnitine (C10) |
53102-0 | Decanoylcarnitine (C10) [Molecules/volume] in Urine | Decanoylcarnitine (C10) |
53504-7 | Decanoylcarnitine (C10)/Creatinine [Molecular ratio] in Urine | Decanoylcarnitine (C10)/Creatinine |
53208-5 | Decatrienoylcarnitine (C10:3) [Molecules/volume] in Blood dot (filter paper) | Decatrienoylcarnitine (C10:3) |
17998-6 | None | Deceleration |
17999-4 | None | Deceleration |
18000-0 | None | Deceleration |
20176-4 | None | Deceleration |
20217-6 | None | Deceleration |
20218-4 | None | Deceleration |
20283-8 | None | Deceleration |
20219-2 | None | Deceleration 2 |
18002-6 | None | Deceleration slope |
20175-6 | None | Deceleration slope |
20216-8 | None | Deceleration slope |
20282-0 | None | Deceleration slope |
20345-5 | None | Deceleration slope |
18003-4 | None | Deceleration time slope |
20215-0 | None | Deceleration.max |
20275-4 | None | Deceleration.pressure half-time |
18001-8 | None | Deceleration.pressure.half time |
20220-0 | None | Deceleration.XXX/Deceleration 2.XXX |
13727-3 | Decenediate/Creatinine [Mass ratio] in Urine | Decenediate/Creatinine |
25094-4 | Decenediate/Creatinine [Molecular ratio] in Urine | Decenediate/Creatinine |
35147-8 | Decenoate (C10:1) [Molecules/volume] in Serum or Plasma | Decenoate |
47614-3 | Decenoate (C10:1)/Creatinine [Molecular ratio] in Urine | Decenoate/Creatinine |
30328-9 | Decenoylcarnitine (C10:1) [Molecules/volume] in Serum or Plasma | Decenoylcarnitine (C10:1) |
45198-9 | Decenoylcarnitine (C10:1) [Molecules/volume] in Blood dot (filter paper) | Decenoylcarnitine (C10:1) |
53057-6 | Decenoylcarnitine (C10:1) [Molecules/volume] in Amniotic Fluid | Decenoylcarnitine (C10:1) |
53076-6 | Decenoylcarnitine (C10:1) [Molecules/volume] in Cerebral spinal fluid | Decenoylcarnitine (C10:1) |
53103-8 | Decenoylcarnitine (C10:1) [Molecules/volume] in Urine | Decenoylcarnitine (C10:1) |
53108-7 | Decenoylcarnitine (C10:1)/Creatinine [Molecular ratio] in Urine | Decenoylcarnitine (C10:1)/Creatinine |
16151-3 | Dechlorane [Presence] in Serum or Plasma | Dechlorane |
16720-5 | Dechlorane [Presence] in Blood | Dechlorane |
52687-1 | None | Decision authority documented |
28086-7 | None | Decisional conflict |
32389-9 | None | Deep tendon reflex |
32390-7 | None | Deep tendon reflex |
32391-5 | None | Deep tendon reflex |
32392-3 | None | Deep tendon reflex |
32393-1 | None | Deep tendon reflex |
32491-3 | None | Deep tendon reflex |
45642-6 | None | Deep vein thrombosis |
10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum | Deer epithelium Ab.IgE |
15679-4 | Deer epithelium IgE Ab RAST class in Serum | Deer epithelium Ab.IgE.RAST class |
11169-0 | Deer hair IgE Ab [Units/volume] in Serum | Deer hair Ab.IgE |
21238-1 | Deer hair IgE Ab RAST class in Serum | Deer hair Ab.IgE.RAST class |
18004-2 | None | Defect.diameter |
18005-9 | None | Defect.diameter |
18008-3 | None | Defect.gradient.systole.max |
18009-1 | None | Defect.gradient.systole.mean |
29461-1 | None | Defect.velocity.systole.max |
28087-5 | None | Defensive coping |
52266-4 | None | Defined school year |
52297-9 | None | Defined school year |
52409-0 | None | Defined school year |
45246-6 | None | Degree of adherence to anti-retroviral drug regimen |
45245-8 | None | Degree of adherence to cotrimoxzole |
45696-2 | None | Dehydrated |
45911-5 | None | Dehydration &or fluid maintenance trigger |
31013-6 | Dehydrochlormethyltestosterone [Mass/volume] in Urine | Dehydrochlormethyltestosterone |
13612-7 | Dehydroepiandrosterone [Mass/time] in 24 hour Urine | Dehydroepiandrosterone |
15054-0 | Dehydroepiandrosterone [Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone |
2193-1 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma | Dehydroepiandrosterone |
2194-9 | Dehydroepiandrosterone [Presence] in Urine | Dehydroepiandrosterone |
2195-6 | Dehydroepiandrosterone [Mass/volume] in Urine | Dehydroepiandrosterone |
25391-4 | Dehydroepiandrosterone [Molecules/time] in 24 hour Urine | Dehydroepiandrosterone |
25895-4 | Dehydroepiandrosterone [Molecules/volume] in 24 hour Urine | Dehydroepiandrosterone |
30029-3 | Dehydroepiandrosterone [Units/volume] in Saliva | Dehydroepiandrosterone |
31020-1 | Dehydroepiandrosterone [Mass/volume] in Amniotic Fluid | Dehydroepiandrosterone |
34279-0 | Dehydroepiandrosterone [Molecules/volume] in Urine | Dehydroepiandrosterone |
35206-2 | Dehydroepiandrosterone [Mass or Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone |
49716-4 | Dehydroepiandrosterone [Mass/volume] in Saliva | Dehydroepiandrosterone |
14688-6 | Dehydroepiandrosterone sulfate [Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone sulfate |
15053-2 | Dehydroepiandrosterone sulfate [Molecules/time] in 24 hour Urine | Dehydroepiandrosterone sulfate |
16721-3 | Dehydroepiandrosterone sulfate [Mass/volume] in Saliva | Dehydroepiandrosterone sulfate |
2190-7 | Dehydroepiandrosterone sulfate [Mass/volume] in Amniotic Fluid | Dehydroepiandrosterone sulfate |
2191-5 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma | Dehydroepiandrosterone sulfate |
2192-3 | Dehydroepiandrosterone sulfate [Mass/time] in 24 hour Urine | Dehydroepiandrosterone sulfate |
34280-8 | Dehydroepiandrosterone sulfate [Molecules/volume] in Urine | Dehydroepiandrosterone sulfate |
34281-6 | Dehydroepiandrosterone sulfate [Molecules/volume] in 24 hour Urine | Dehydroepiandrosterone sulfate |
35205-4 | Dehydroepiandrosterone sulfate [Mass or Molecules/volume] in Serum or Plasma | Dehydroepiandrosterone sulfate |
34282-4 | Dehydroepiandrosterone sulfate/Creatinine [Molecular ratio] in Urine | Dehydroepiandrosterone sulfate/Creatinine |
16722-1 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge | Dehydroepiandrosterone sulfate^10th specimen post XXX challenge |
49888-1 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin | Dehydroepiandrosterone sulfate^1H post dose corticotropin |
16723-9 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | Dehydroepiandrosterone sulfate^2nd specimen post XXX challenge |
16724-7 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | Dehydroepiandrosterone sulfate^3rd specimen post XXX challenge |
16725-4 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | Dehydroepiandrosterone sulfate^4th specimen post XXX challenge |
16726-2 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | Dehydroepiandrosterone sulfate^5th specimen post XXX challenge |
16727-0 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | Dehydroepiandrosterone sulfate^6th specimen post XXX challenge |
16728-8 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Dehydroepiandrosterone sulfate^7th specimen post XXX challenge |
16729-6 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | Dehydroepiandrosterone sulfate^8th specimen post XXX challenge |
16730-4 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | Dehydroepiandrosterone sulfate^9th specimen post XXX challenge |
49889-9 | Dehydroepiandrosterone sulfate [Mass/volume] in Serum or Plasma --pre dose corticotropin | Dehydroepiandrosterone sulfate^pre dose corticotropin |
16731-2 | None | Dehydroepiandrosterone.unconjugated |
2196-4 | Dehydroepiandrosterone.unconjugated [Mass/volume] in Serum or Plasma | Dehydroepiandrosterone.unconjugated |
2197-2 | Dehydroepiandrosterone.unconjugated [Mass/time] in 24 hour Urine | Dehydroepiandrosterone.unconjugated |
29879-4 | Dehydroepiandrosterone/Creatinine [Mass ratio] in 24 hour Urine | Dehydroepiandrosterone/Creatinine |
34283-2 | Dehydroepiandrosterone/Creatinine [Molecular ratio] in Urine | Dehydroepiandrosterone/Creatinine |
13862-8 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin | Dehydroepiandrosterone^15M post 250 ug corticotropin |
13863-6 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin | Dehydroepiandrosterone^1H post 250 ug corticotropin |
49887-3 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge | Dehydroepiandrosterone^1st specimen post XXX challenge |
12590-6 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | Dehydroepiandrosterone^2nd specimen post XXX challenge |
13864-4 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin | Dehydroepiandrosterone^30M post 250 ug corticotropin |
12591-4 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | Dehydroepiandrosterone^3rd specimen post XXX challenge |
12592-2 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | Dehydroepiandrosterone^4th specimen post XXX challenge |
12593-0 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | Dehydroepiandrosterone^5th specimen post XXX challenge |
12594-8 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | Dehydroepiandrosterone^6th specimen post XXX challenge |
16732-0 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Dehydroepiandrosterone^7th specimen post XXX challenge |
16733-8 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | Dehydroepiandrosterone^9th specimen post XXX challenge |
16734-6 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --baseline | Dehydroepiandrosterone^baseline |
16735-3 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --post XXX challenge | Dehydroepiandrosterone^post XXX challenge |
47852-9 | Dehydroepiandrosterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin | Dehydroepiandrosterone^pre 250 ug corticotropin |
53211-9 | Dehydrosebacylcarnitine (C10:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dehydrosebacylcarnitine (C10:1-DC) |
53209-3 | Dehydrosuberylcarnitine (C8:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dehydrosuberylcarnitine (C8:1-DC) |
42634-6 | Del(1p,19q) gene deletion [Presence] in Fixed tissue by Molecular genetics method | Del(1p,19q) gene deletion |
42715-3 | del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal | Del(5)(q12-35) gene deletion |
27082-7 | Delavirdine [Mass/volume] in Serum or Plasma | Delavirdine |
29115-3 | Delavirdine [Units/volume] in Serum or Plasma | Delavirdine |
30276-0 | Delavirdine [Susceptibility] by Phenotype method | Delavirdine |
30290-1 | Delavirdine [Susceptibility] by Genotype method | Delavirdine |
30305-7 | Delavirdine [Susceptibility] | Delavirdine |
52586-5 | None | Delayed healing of surgical wound |
45896-8 | None | Delirium trigger |
11778-8 | None | Delivery date |
11779-6 | None | Delivery date |
11780-4 | None | Delivery date |
11781-2 | None | Delivery date |
53692-0 | None | Delivery date |
53694-6 | None | Delivery date |
42840-9 | None | Delivery risk |
18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine | Delta 5-Pregnanetriol |
6699-3 | Delta 5-Pregnanetriol [Mass/time] in 24 hour Urine | Delta 5-Pregnanetriol |
18215-4 | Delta alanine [Mass/volume] in Urine | Delta alanine |
11215-1 | Delta aminolevulinate [Mass/volume] in Urine | Delta aminolevulinate |
12475-0 | Delta aminolevulinate [Mass/time] in Urine | Delta aminolevulinate |
14689-4 | Delta aminolevulinate [Molecules/time] in 24 hour Urine | Delta aminolevulinate |
2198-0 | Delta aminolevulinate [Mass/volume] in Plasma | Delta aminolevulinate |
2199-8 | Delta aminolevulinate [Mass/volume] in Serum | Delta aminolevulinate |
2200-4 | Delta aminolevulinate [Mass/time] in 24 hour Urine | Delta aminolevulinate |
25896-2 | Delta aminolevulinate [Molecules/volume] in 24 hour Urine | Delta aminolevulinate |
26974-6 | Delta aminolevulinate [Mass/volume] in 24 hour Urine | Delta aminolevulinate |
34284-0 | Delta aminolevulinate [Molecules/volume] in Urine | Delta aminolevulinate |
47088-0 | Delta aminolevulinate [Molecules/volume] in Serum | Delta aminolevulinate |
13728-1 | Delta aminolevulinate/Creatinine [Mass ratio] in Urine | Delta aminolevulinate/Creatinine |
25897-0 | Delta aminolevulinate/Creatinine [Molecular ratio] in 24 hour Urine | Delta aminolevulinate/Creatinine |
39782-8 | Delta aminolevulinate/Creatinine [Molecular ratio] in Urine | Delta aminolevulinate/Creatinine |
44313-5 | Delta aminolevulinate/Creatinine [Mass ratio] in 24 hour Urine | Delta aminolevulinate/Creatinine |
13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma | Delta tocopherol |
45698-8 | None | Delusions |
11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum | Dematiaceae Ab.IgE |
10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma | Demeclocycline |
18915-9 | Demeclocycline [Susceptibility] | Demeclocycline |
216-2 | Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC) | Demeclocycline |
217-0 | Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Demeclocycline |
218-8 | Demeclocycline [Susceptibility] by Disk diffusion (KB) | Demeclocycline |
219-6 | Demeclocycline [Susceptibility] by Serum bactericidal titer | Demeclocycline |
29494-2 | Demeclocycline [Mass/volume] in Unspecified specimen | Demeclocycline |
7006-0 | Demeclocycline [Susceptibility] by Gradient strip (E-test) | Demeclocycline |
45656-6 | None | Dementia other than Alzheimer's disease |
45970-1 | None | Demographic information section |
47246-4 | None | Demographic information section |
46439-6 | None | Demographic section |
12377-8 | Demoxepam [Mass/volume] in Serum or Plasma | Demoxepam |
13556-6 | Demoxepam [Presence] in Serum or Plasma | Demoxepam |
16736-1 | Dengue virus 1 Ab [Titer] in Serum | Dengue virus 1 Ab |
22250-5 | Dengue virus 1 Ab [Presence] in Serum | Dengue virus 1 Ab |
31338-7 | Dengue virus 1 Ab [Units/volume] in Serum | Dengue virus 1 Ab |
7854-3 | Dengue virus 1 Ab [Presence] in Serum by Immunoassay | Dengue virus 1 Ab |
7855-0 | Dengue virus 1+2+3+4 RNA [Presence] in Serum by Probe & target amplification method | Dengue virus 1+2+3+4 RNA |
16737-9 | Dengue virus 2 Ab [Titer] in Serum | Dengue virus 2 Ab |
22251-3 | Dengue virus 2 Ab [Presence] in Serum | Dengue virus 2 Ab |
31339-5 | Dengue virus 2 Ab [Units/volume] in Serum | Dengue virus 2 Ab |
7856-8 | Dengue virus 2 Ab [Presence] in Serum by Immunoassay | Dengue virus 2 Ab |
16738-7 | Dengue virus 3 Ab [Titer] in Serum | Dengue virus 3 Ab |
22252-1 | Dengue virus 3 Ab [Presence] in Serum | Dengue virus 3 Ab |
31340-3 | Dengue virus 3 Ab [Units/volume] in Serum | Dengue virus 3 Ab |
7857-6 | Dengue virus 3 Ab [Presence] in Serum by Immunoassay | Dengue virus 3 Ab |
16739-5 | Dengue virus 4 Ab [Titer] in Serum | Dengue virus 4 Ab |
22253-9 | Dengue virus 4 Ab [Presence] in Serum | Dengue virus 4 Ab |
31341-1 | Dengue virus 4 Ab [Units/volume] in Serum | Dengue virus 4 Ab |
7858-4 | Dengue virus 4 Ab [Presence] in Serum by Immunoassay | Dengue virus 4 Ab |
16740-3 | Dengue virus Ab [Presence] in Serum | Dengue virus Ab |
31342-9 | Dengue virus Ab [Units/volume] in Unspecified specimen | Dengue virus Ab |
31343-7 | Dengue virus Ab [Presence] in Unspecified specimen | Dengue virus Ab |
33578-6 | Dengue virus Ab [Titer] in Serum by Immunofluorescence | Dengue virus Ab |
33606-5 | Dengue virus Ab [Titer] in Serum | Dengue virus Ab |
40515-9 | Dengue virus Ab [Titer] in Serum by Complement fixation | Dengue virus Ab |
40748-6 | Dengue virus Ab [Presence] in Serum by Hemaglutination inhibition | Dengue virus Ab |
50036-3 | Dengue virus Ab [Presence] in Unspecified specimen by Neutralization test | Dengue virus Ab |
6382-6 | None | Dengue virus Ab |
6383-4 | None | Dengue virus Ab |
7859-2 | Dengue virus Ab [Units/volume] in Serum | Dengue virus Ab |
23958-2 | Dengue virus IgG Ab [Units/volume] in Serum | Dengue virus Ab.IgG |
23991-3 | Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay | Dengue virus Ab.IgG |
29661-6 | Dengue virus IgG Ab [Presence] in Serum by Immunoassay | Dengue virus Ab.IgG |
29676-4 | Dengue virus IgG Ab [Presence] in Serum | Dengue virus Ab.IgG |
6811-4 | Dengue virus IgG Ab [Titer] in Serum | Dengue virus Ab.IgG |
51785-4 | Dengue virus Ab.IgG & IgM [interpretation] in Serum | Dengue virus Ab.IgG & IgM |
41878-0 | Dengue virus IgG & IgM panel [Units/volume] in Serum by Immunoassay | Dengue virus Ab.IgG & IgM panel |
23968-1 | Dengue virus IgM Ab [Units/volume] in Serum | Dengue virus Ab.IgM |
23992-1 | Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay | Dengue virus Ab.IgM |
25338-5 | Dengue virus IgM Ab [Presence] in Serum | Dengue virus Ab.IgM |
25392-2 | Dengue virus IgM Ab [Presence] in Serum by Immunoblot (IB) | Dengue virus Ab.IgM |
29663-2 | Dengue virus IgM Ab [Presence] in Serum by Immunoassay | Dengue virus Ab.IgM |
34721-1 | Dengue virus IgM Ab [Presence] in Cerebral spinal fluid | Dengue virus Ab.IgM |
6812-2 | Dengue virus IgM Ab [Titer] in Serum | Dengue virus Ab.IgM |
31798-2 | Dengue virus Ag [Presence] in Serum | Dengue virus Ag |
31799-0 | Dengue virus Ag [Presence] in Unspecified specimen | Dengue virus Ag |
6384-2 | Dengue virus Ag [Presence] in Serum by Immunofluorescence | Dengue virus Ag |
6385-9 | Dengue virus Ag [Presence] in Unspecified specimen by Immunofluorescence | Dengue virus Ag |
6386-7 | Dengue virus DNA [Presence] in Serum by DNA probe | Dengue virus DNA |
6387-5 | Dengue virus DNA [Presence] in Unspecified specimen by DNA probe | Dengue virus DNA |
28088-3 | None | Denial |
32883-1 | None | Dental arch |
45912-3 | None | Dental care trigger |
34043-0 | None | Dental examination method |
34047-1 | None | Dental history contribution |
34048-9 | None | Dental material used &or Proposed |
34016-6 | None | Dental plaque |
32881-5 | None | Dental probing response |
32964-9 | None | Dental prognosis |
32965-6 | None | Dental prognosis |
32966-4 | None | Dental prognosis |
34026-5 | None | Dental prosthesis |
39173-0 | None | Dental screen assessment |
39176-3 | None | Dental screen finding recency |
39175-5 | None | Dental screen follow-up status |
39174-8 | None | Dental screen results indicator |
32874-0 | None | Dental treatment anatomical site access |
52040-3 | Dental X-rays and Other Images (Not DICOM) | Dental X-rays and other images (not DICOM) attachment |
28266-5 | None | Dentition.behavior |
28459-6 | None | Dentition.behavior |
28267-3 | None | Dentition.knowledge |
28460-4 | None | Dentition.knowledge |
28268-1 | None | Dentition.status |
28461-2 | None | Dentition.status |
34031-5 | None | Denture base evaluation |
34033-1 | None | Denture occlusion |
34032-3 | None | Denture teeth evaluation |
2201-2 | Deoxycholate [Mass/volume] in Serum | Deoxycholate |
30520-1 | Deoxycholate [Molecules/volume] in Serum | Deoxycholate |
2202-0 | Deoxycholylglycine [Mass/volume] in Serum | Deoxycholylglycine |
39533-5 | Deoxyhemoglobin [Mass/volume] in Blood | Deoxyhemoglobin |
19225-2 | Deoxyhemoglobin/Hemoglobin.total in Arterial blood | Deoxyhemoglobin/Hemoglobin.total |
19226-0 | Deoxyhemoglobin/Hemoglobin.total in Capillary blood | Deoxyhemoglobin/Hemoglobin.total |
19227-8 | Deoxyhemoglobin/Hemoglobin.total in Venous blood | Deoxyhemoglobin/Hemoglobin.total |
19228-6 | Deoxyhemoglobin/Hemoglobin.total in Mixed venous blood | Deoxyhemoglobin/Hemoglobin.total |
4536-9 | Deoxyhemoglobin/Hemoglobin.total in Blood | Deoxyhemoglobin/Hemoglobin.total |
11216-9 | Deoxypyridinoline [Mass/volume] in Urine | Deoxypyridinoline |
15055-7 | Deoxypyridinoline [Molecules/time] in 24 hour Urine | Deoxypyridinoline |
15056-5 | None | Deoxypyridinoline |
25898-8 | Deoxypyridinoline [Molecules/volume] in 24 hour Urine | Deoxypyridinoline |
27424-1 | Deoxypyridinoline [Molecules/volume] in Urine | Deoxypyridinoline |
6936-9 | Deoxypyridinoline [Mass/time] in 2 hour Urine | Deoxypyridinoline |
6937-7 | Deoxypyridinoline [Mass/time] in 24 hour Urine | Deoxypyridinoline |
13881-8 | Deoxypyridinoline Free/Creatinine [Molecular ratio] in Urine | Deoxypyridinoline.free/Creatinine |
13729-9 | Deoxypyridinoline/Creatinine [Mass ratio] in Urine | Deoxypyridinoline/Creatinine |
13730-7 | Deoxypyridinoline/Creatinine [Mass ratio] in 24 hour Urine | Deoxypyridinoline/Creatinine |
13731-5 | Deoxypyridinoline/Creatinine [Mass ratio] in 2 hour Urine | Deoxypyridinoline/Creatinine |
24456-6 | Deoxypyridinoline/Creatinine [Molecular ratio] in 24 hour Urine | Deoxypyridinoline/Creatinine |
25095-1 | Deoxypyridinoline/Creatinine [Molecular ratio] in Urine | Deoxypyridinoline/Creatinine |
25096-9 | Deoxypyridinoline/Creatinine [Molecular ratio] in 2 hour Urine | Deoxypyridinoline/Creatinine |
35646-9 | Deoxypyridinoline/Creatinine [Molecular ratio] in unspecified time Urine | Deoxypyridinoline/Creatinine |
5129-2 | Deoxyribonuclease Ab [Units/volume] in Serum | Deoxyribonuclease Ab |
13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum | Deoxyribonucleoprotein Ab |
47957-6 | Deoxyuridine [Molecules/volume] in Serum or Plasma | Deoxyuridine |
34087-7 | None | Dependence section |
28378-8 | None | Depression |
45666-5 | None | Depression |
46472-7 | None | Depressive feelings |
39114-4 | None | Depth |
39127-6 | None | Depth |
9798-0 | Depth of Stone | Depth |
44661-7 | None | Depth of invasion by tumor |
44662-5 | None | Depth of invasion by tumor cannot be determined comment |
46671-4 | None | Depth perception |
21839-6 | None | Derivation method |
42103-2 | None | Derived American Joint Committee on cancer conversion method |
42098-4 | None | Derived American Joint Committee on Cancer M |
42099-2 | None | Derived American Joint Committee on Cancer M descriptor |
42096-8 | None | Derived American Joint Committee on Cancer N |
42097-6 | None | Derived American Joint Committee on Cancer N descriptor |
42100-8 | None | Derived American Joint Committee on Cancer stage group |
42094-3 | None | Derived American Joint Committee on Cancer T |
42095-0 | None | Derived American Joint Committee on Cancer T descriptor |
42101-6 | None | Derived SEER summary stage 1977 |
42104-0 | None | Derived SEER summary stage 1977 conversion method |
42102-4 | None | Derived SEER summary stage 2000 |
42105-7 | None | Derived SEER summary stage 2000 conversion method |
2203-8 | Dermatan sulfate [Mass/volume] in Serum or Plasma | Dermatan sulfate |
2204-6 | Dermatan sulfate [Mass/volume] in Urine | Dermatan sulfate |
47615-0 | Dermatan sulfate [Presence] in Urine | Dermatan sulfate |
44461-2 | American house dust mite Ab [Presence] in Serum by Immune diffusion (ID) | Dermatophagoides farinae Ab |
6095-4 | American house dust mite IgE Ab [Units/volume] in Serum | Dermatophagoides farinae Ab.IgE |
15680-2 | American house dust mite IgE Ab RAST class in Serum | Dermatophagoides farinae Ab.IgE.RAST class |
16741-1 | American house dust mite IgG Ab [Presence] in Blood | Dermatophagoides farinae Ab.IgG |
51534-6 | American house dust mite IgG Ab [Presence] in Serum | Dermatophagoides farinae Ab.IgG |
7276-9 | American house dust mite IgG Ab [Units/volume] in Serum | Dermatophagoides farinae Ab.IgG |
26419-2 | American house dust mite IgG4 Ab [Units/volume] in Serum | Dermatophagoides farinae Ab.IgG4 |
26420-0 | American house dust mite IgG4 Ab RAST class in Serum | Dermatophagoides farinae Ab.IgG4.RAST class |
7277-7 | American house dust mite triggered histamine release [Units/volume] in Blood | Dermatophagoides farinae basophil bound Ab |
48235-6 | American house dust mite triggered leukotriene release [Mass/volume] by Leukocytes | Dermatophagoides farinae leukotriene release |
14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum | Dermatophagoides microceras Ab.IgE |
15681-0 | Dermatophagoides microceras IgE Ab RAST class in Serum | Dermatophagoides microceras Ab.IgE.RAST class |
6096-2 | European house dust mite IgE Ab [Units/volume] in Serum | Dermatophagoides pteronyssinus Ab.IgE |
15682-8 | European house dust mite IgE Ab RAST class in Serum | Dermatophagoides pteronyssinus Ab.IgE.RAST class |
16742-9 | European house dust mite IgG Ab [Presence] in Blood | Dermatophagoides pteronyssinus Ab.IgG |
51533-8 | European house dust mite IgG Ab [Presence] in Serum | Dermatophagoides pteronyssinus Ab.IgG |
7278-5 | European house dust mite IgG Ab [Units/volume] in Serum | Dermatophagoides pteronyssinus Ab.IgG |
26421-8 | European house dust mite IgG4 Ab [Units/volume] in Serum | Dermatophagoides pteronyssinus Ab.IgG4 |
26422-6 | European house dust mite IgG4 Ab RAST class in Serum | Dermatophagoides pteronyssinus Ab.IgG4.RAST class |
7279-3 | European house dust mite triggered histamine release [Units/volume] in Blood | Dermatophagoides pteronyssinus basophil bound Ab |
48236-4 | European house dust mite triggered leukotriene release [Mass/volume] by Leukocytes | Dermatophagoides pteronyssinus leukotriene release |
41271-8 | Dermatophagoides sp IgE Ab [Units/volume] in Serum | Dermatophagoides sp Ab.IgE |
43276-5 | Dermatophagoides sp IgE Ab RAST class in Serum | Dermatophagoides sp Ab.IgE.RAST class |
23025-0 | Dermatophilus congolensis [Presence] in Skin by Giemsa stain | Dermatophilus congolensis |
23595-2 | Dermatophilus congolensis [Presence] in Exudate by Giemsa stain | Dermatophilus congolensis |
23596-0 | Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain | Dermatophilus congolensis |
23597-8 | Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain | Dermatophilus congolensis |
23026-8 | Dermatophilus congolensis Ab [Presence] in Serum | Dermatophilus congolensis Ab |
23027-6 | Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay | Dermatophilus congolensis Ab |
23028-4 | Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence | Dermatophilus congolensis Ag |
23598-6 | Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence | Dermatophilus congolensis Ag |
31800-6 | Dermatophilus congolensis Ag [Presence] in Exudate | Dermatophilus congolensis Ag |
21239-9 | Desalkylhalazepam [Mass/volume] in Serum or Plasma | Desalkylhalazepam |
51195-6 | Desbutylbupivacaine [Mass/volume] in Serum or Plasma | Desbutylbupivacaine |
52019-7 | Ambulance transport, description of services performed to support level of service | Description of services performed to support level of service |
34089-3 | None | Description section |
21909-7 | None | Descriptor.clinical |
21916-2 | None | Descriptor.other |
21903-0 | None | Descriptor.pathology |
25393-0 | Desethylamiodarone [Molecules/volume] in Serum or Plasma | Desethylamiodarone |
4211-9 | Desethylamiodarone [Mass] of Dose | Desethylamiodarone |
6774-4 | Desethylamiodarone [Mass/volume] in Serum or Plasma | Desethylamiodarone |
14691-0 | Desipramine [Molecules/volume] in Serum or Plasma | Desipramine |
14692-8 | Desipramine [Molecules/volume] in Urine | Desipramine |
29409-0 | Desipramine [Mass/volume] in Gastric fluid | Desipramine |
3531-1 | Desipramine [Mass/volume] in Serum or Plasma | Desipramine |
3532-9 | Desipramine [Presence] in Serum or Plasma | Desipramine |
3533-7 | Desipramine [Presence] in Urine | Desipramine |
3534-5 | Desipramine [Mass/volume] in Urine | Desipramine |
35606-3 | Desipramine [Mass/volume] in Serum or Plasma by Screen method | Desipramine |
40358-4 | Desipramine [Presence] in Gastric fluid | Desipramine |
4212-7 | Desipramine [Mass] of Dose | Desipramine |
3535-2 | Desipramine [Mass/volume] in Serum or Plasma --trough | Desipramine^trough |
9698-2 | None | Desmethylclomipramine |
12385-1 | None | Desmethyldoxepin |
16745-2 | None | Desmethylmethsuximide |
10476-0 | Desmin Ag [Presence] in Tissue by Immune stain | Desmin Ag |
43309-4 | Desmoglein 1 & Desmoglein 3 Ab panel [Units/volume] in Serum | Desmoglein 1 & Desmoglein 3 Ab panel |
43311-0 | Desmoglein 1 Ab [Units/volume] in Serum | Desmoglein 1 Ab |
43312-8 | Desmoglein 3 Ab [Units/volume] in Serum | Desmoglein 3 Ab |
11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma | Despropionylfentanyl |
11073-4 | Despropionylfentanyl [Mass/volume] in Urine | Despropionylfentanyl |
18582-7 | Ambulance transport destination site name | Destination site |
18583-5 | Ambulance transport, destination site address | Destination site |
15512-7 | Ambulance transport, destination site information (composite) | Destination site information |
52002-3 | Latitude coordinate | Destination site latitude |
52003-1 | Longitude coordinate | Destination site longitude |
52026-2 | Ambulance transport,destination site information - name and address | Destination site name & address |
51899-3 | None | Details |
14696-9 | Deuteroporphyrin [Molecules/volume] in Stool | Deuteroporphyrin |
23852-7 | Deuteroporphyrin [Mass/time] in unspecified time Stool | Deuteroporphyrin |
45307-6 | Deuteroporphyrin [Molecules/mass] in Stool | Deuteroporphyrin |
33619-8 | Deuteroporphyrin.semi-proto [Mass/time] in 24 hour Stool | Deuteroporphyrin.semi-proto |
44615-3 | None | Device error code |
46067-5 | None | Devices and restraints |
14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma | Dexamethasone |
46948-6 | Dexamethasone [Mass/volume] in Urine | Dexamethasone |
15366-8 | Dextroamphetamine [Mass/volume] in Urine | Dextroamphetamine |
19419-1 | Dextroamphetamine [Presence] in Urine by Screen method | Dextroamphetamine |
19420-9 | Dextroamphetamine [Presence] in Urine by Confirm method | Dextroamphetamine |
20525-2 | Dextroamphetamine [Mass/volume] in Urine by Confirm method | Dextroamphetamine |
9814-5 | Dextroamphetamine [Mass/volume] in Serum or Plasma | Dextroamphetamine |
19421-7 | Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method | Dextroamphetamine cutoff |
19422-5 | Dextroamphetamine cutoff [Mass/volume] in Urine for Confirm method | Dextroamphetamine cutoff |
31025-0 | Dextroamphetamine/Amphetamines.total in Urine | Dextroamphetamine/Amphetamines.total |
13497-3 | Dextroamphetamine/Levoamphetamine [Mass ratio] in Urine | Dextroamphetamine/Levoamphetamine |
32642-1 | Dextroamphetamine/Levoamphetamine [Mass ratio] in Serum or Plasma | Dextroamphetamine/Levoamphetamine |
12477-6 | Dextromethamphetamine [Mass/volume] in Urine | Dextromethamphetamine |
19423-3 | Dextromethamphetamine [Presence] in Urine by Screen method | Dextromethamphetamine |
19424-1 | Dextromethamphetamine [Presence] in Urine by Confirm method | Dextromethamphetamine |
19425-8 | Dextromethamphetamine [Mass/volume] in Urine by Confirm method | Dextromethamphetamine |
19426-6 | None | Dextromethamphetamine |
19427-4 | Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method | Dextromethamphetamine cutoff |
19428-2 | Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirm method | Dextromethamphetamine cutoff |
31026-8 | Dextromethamphetamine/Amphetamines.total in Urine | Dextromethamphetamine/Amphetamines.total |
13498-1 | Dextromethamphetamine/Levomethamphetamine [Mass ratio] in Urine | Dextromethamphetamine/Levomethamphetamine |
32643-9 | Dextromethamphetamine/Levomethamphetamine [Mass ratio] in Serum or Plasma | Dextromethamphetamine/Levomethamphetamine |
13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma | Dextromethorphan |
16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirm method | Dextromethorphan |
21240-7 | Dextromethorphan [Mass/volume] in Urine | Dextromethorphan |
27413-4 | Dextromethorphan [Units/volume] in Serum or Plasma | Dextromethorphan |
3538-6 | Dextromethorphan [Presence] in Serum or Plasma | Dextromethorphan |
3539-4 | Dextromethorphan [Presence] in Urine | Dextromethorphan |
40359-2 | Dextromethorphan [Presence] in Unspecified specimen | Dextromethorphan |
4214-3 | Dextromethorphan [Mass] of Dose | Dextromethorphan |
52947-9 | Dextromethorphan [Presence] in Gastric fluid | Dextromethorphan |
27076-9 | Dextromethorphan+Levorphanol [Presence] in Urine | Dextromethorphan+Levorphanol |
16747-8 | Dextromoramide [Presence] in Serum or Plasma | Dextromoramide |
3540-2 | Dextromoramide [Presence] in Urine | Dextromoramide |
3541-0 | Dextromoramide [Mass/volume] in Urine | Dextromoramide |
4215-0 | Dextromoramide [Mass] of Dose | Dextromoramide |
14063-2 | Dezocine [Presence] in Urine | Dezocine |
16750-2 | Dezocine [Mass/volume] in Serum or Plasma | Dezocine |
16751-0 | Dezocine [Mass/volume] in Blood | Dezocine |
18216-2 | Dezocine [Presence] in Urine by Confirm method | Dezocine |
38297-8 | Di(2-Ethylhexyl) phthalate [Mass/volume] in Water | Di(2-Ethylhexyl) phthalate |
38636-7 | Di(2-Ethylhexyl) phthalate [Mass/volume] in Air | Di(2-Ethylhexyl) phthalate |
45636-8 | None | Diabetes mellitus |
33248-6 | Diabetes status [Identifier] | Diabetes status |
52588-1 | None | Diabetic foot ulcer(s) |
45672-3 | None | Diabetic retinopathy |
16752-8 | Diacetate [Presence] in Urine | Diacetate |
2205-3 | Diacetate [Mass/volume] in Serum | Diacetate |
19806-9 | None | Diagnosis |
19807-7 | None | Diagnosis |
19808-5 | None | Diagnosis |
19809-3 | None | Diagnosis |
19810-1 | None | Diagnosis |
19811-9 | None | Diagnosis |
29308-4 | None | Diagnosis |
29548-5 | None | Diagnosis |
46609-4 | None | Diagnosis and severity index |
52797-8 | None | Diagnosis ICD code |
39221-7 | None | Diagnosis recommendations |
39223-3 | None | Diagnosis recommendations, description |
39222-5 | None | Diagnosis recommendations, ICD9-CM |
18631-2 | Psychiatric rehabilitation treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
18821-9 | Psychiatric rehabilitation treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
18822-7 | Psychiatric rehabilitation treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
27465-4 | Cardiac rehabilitation treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
27466-2 | Cardiac rehabilitation treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
27477-9 | Alcohol-substance abuse rehabilitation treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
27518-0 | Cardiac rehabilitation treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
27528-9 | Alcohol-substance abuse rehabilitation treatment plan, diagnosis addressed by plan | Diagnosis.addressed by plan |
27529-7 | Alcohol-substance abuse rehabilitation treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
27550-3 | Skilled nursing treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
27592-5 | Skilled nursing treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
27593-3 | Skilled nursing treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
27601-4 | Occupational therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
27643-6 | Occupational therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
27644-4 | Occupational therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
27655-0 | Physical therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
27656-8 | Physical therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
27664-2 | Physical therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
27703-8 | Respiratory therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
27745-9 | Respiratory therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
27746-7 | Respiratory therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
27754-1 | Medical social services treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
27796-2 | Medical social services treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
27797-0 | Medical social services treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
29167-4 | Speech therapy treatment plan, diagnosis addressed by plan (composite) | Diagnosis.addressed by plan |
29192-2 | Speech therapy treatment plan, diagnosis addressed by plan (identifier) | Diagnosis.addressed by plan |
29193-0 | Speech therapy treatment plan, diagnosis addressed by plan (text) | Diagnosis.addressed by plan |
52142-7 | None | Diagnosis.addressed by plan |
52302-7 | None | Diagnosis.addressed by plan |
44833-2 | None | Diagnosis.preliminary |
18630-4 | Primary diagnosis | Diagnosis.primary |
18777-3 | Psychiatric rehabilitation treatment plan, primary diagnosis (text) | Diagnosis.primary |
18820-1 | Psychiatric rehabilitation treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
19007-4 | Psychiatric rehabilitation treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27457-1 | Cardiac rehabilitation treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27460-5 | Cardiac rehabilitation treatment plan, primary diagnosis (text) | Diagnosis.primary |
27464-7 | Cardiac rehabilitation treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
27515-6 | Alcohol-substance abuse rehabilitation treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27523-0 | Alcohol-substance abuse rehabilitation treatment plan, primary diagnosis (text) | Diagnosis.primary |
27527-1 | Alcohol-substance abuse rehabilitation treatment plan, primary diagnosis | Diagnosis.primary |
27584-2 | Skilled nursing treatment plan, primary diagnosis (text) | Diagnosis.primary |
27587-5 | Skilled nursing treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27591-7 | Skilled nursing treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
27635-2 | Occupational therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27638-6 | Occupational therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
27642-8 | Occupational therapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
27650-1 | Physical therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
27654-3 | Physical therapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
27698-0 | Physical therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27737-6 | Respiratory therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
27740-0 | Respiratory therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27744-2 | Respiratory therapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
27788-9 | Medical social services treatment plan, primary diagnosis (text) | Diagnosis.primary |
27791-3 | Medical social services treatment plan, primary diagnosis (composite) | Diagnosis.primary |
27795-4 | Medical social services treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
29166-6 | Speech therapy treatment plan, primary diagnosis (composite) | Diagnosis.primary |
29194-8 | Speech therapy treatment plan, primary diagnosis (text) | Diagnosis.primary |
29195-5 | Speech thereapy treatment plan, primary diagnosis (identifier) | Diagnosis.primary |
46639-1 | None | Diagnosis.primary |
52137-7 | None | Diagnosis.primary |
52138-5 | None | Diagnosis.primary |
47048-4 | None | Diagnostic interventional study report |
27899-4 | Diagnostic studies non-lab (set) | Diagnostic studies.non lab |
16753-6 | None | Dialtrazene |
45842-2 | None | Dialysis |
42605-6 | Peritoneal dialysis bag number | Dialysis bag number |
29749-9 | Dialysis records | Dialysis records |
11782-0 | None | Diameter |
11783-8 | None | Diameter |
11784-6 | None | Diameter |
11785-3 | None | Diameter |
11786-1 | None | Diameter |
11787-9 | None | Diameter |
11788-7 | None | Diameter |
11789-5 | None | Diameter |
11790-3 | None | Diameter |
11791-1 | None | Diameter |
11792-9 | None | Diameter |
11793-7 | None | Diameter |
11794-5 | None | Diameter |
11795-2 | None | Diameter |
11796-0 | None | Diameter |
11797-8 | None | Diameter |
11798-6 | None | Diameter |
11799-4 | None | Diameter |
11800-0 | None | Diameter |
11801-8 | None | Diameter |
11802-6 | None | Diameter |
11803-4 | None | Diameter |
11804-2 | None | Diameter |
11805-9 | None | Diameter |
11806-7 | None | Diameter |
11807-5 | None | Diameter |
11808-3 | None | Diameter |
11809-1 | None | Diameter |
11810-9 | None | Diameter |
11811-7 | None | Diameter |
11812-5 | None | Diameter |
11813-3 | None | Diameter |
11814-1 | None | Diameter |
11815-8 | None | Diameter |
11816-6 | None | Diameter |
18006-7 | None | Diameter |
18007-5 | None | Diameter |
18010-9 | None | Diameter |
18011-7 | None | Diameter |
18012-5 | None | Diameter |
18013-3 | None | Diameter |
18014-1 | None | Diameter |
18015-8 | None | Diameter |
18016-6 | None | Diameter |
18017-4 | None | Diameter |
18018-2 | None | Diameter |
18019-0 | None | Diameter |
18020-8 | None | Diameter |
18021-6 | None | Diameter |
18022-4 | None | Diameter |
18023-2 | None | Diameter |
20166-5 | None | Diameter |
20272-1 | None | Diameter |
20307-5 | None | Diameter |
28882-9 | None | Diameter |
33171-0 | None | Diameter |
33441-7 | None | Diameter |
53658-1 | None | Diameter |
53669-8 | None | Diameter |
53671-4 | None | Diameter |
53672-2 | None | Diameter |
20273-9 | None | Diameter 2 |
33150-4 | None | Diameter product |
33191-8 | None | Diameter product |
11817-4 | None | Diameter product.largest pocket |
20348-9 | None | Diameter.4 chamber |
11818-2 | None | Diameter.anterior-posterior |
11819-0 | None | Diameter.anterior-posterior |
53656-5 | None | Diameter.anterior-posterior |
53683-9 | None | Diameter.anterior-posterior |
8294-1 | None | Diameter.anterior-posterior |
18024-0 | None | Diameter.anterior-posterior.systole |
29468-6 | None | Diameter.anterior-posterior.systole |
18025-7 | None | Diameter.anterior-posterior.systole/Diameter.aorta root |
8295-8 | None | Diameter.anterior-posterior^W expiration |
8296-6 | None | Diameter.anterior-posterior^W inspiration |
52728-3 | None | Diameter.any.max |
11820-8 | None | Diameter.biparietal |
33151-2 | None | Diameter.biparietal |
33153-8 | None | Diameter.biparietal |
33154-6 | None | Diameter.biparietal |
33155-3 | None | Diameter.biparietal |
33156-1 | None | Diameter.biparietal |
33198-3 | None | Diameter.biparietal |
33556-2 | None | Diameter.biparietal outer to inner |
33152-0 | None | Diameter.biparietal outer to outer |
11821-6 | None | Diameter.biparietal.mean |
11822-4 | None | Diameter.biparietal.mean |
11823-2 | None | Diameter.biparietal/Diameter.occipital |
33157-9 | None | Diameter.biparietal/Diameter.occipital |
33158-7 | None | Diameter.biparietal/Diameter.occipital |
11824-0 | None | Diameter.BPD.area-corrected |
53673-0 | None | Diameter.diastole |
53685-4 | None | Diameter.diastole |
11825-7 | None | Diameter.hilum-cortex |
11826-5 | None | Diameter.hilum-cortex |
11827-3 | None | Diameter.hilum-cortex |
11828-1 | None | Diameter.hilum-cortex |
11829-9 | None | Diameter.hilum-cortex |
11830-7 | None | Diameter.hilum-cortex |
11831-5 | None | Diameter.hilum-cortex.mean |
33070-4 | None | Diameter.inner orbital |
11832-3 | None | Diameter.largest pocket.max |
11833-1 | None | Diameter.largest pocket.mean |
38181-4 | None | Diameter.lateral |
11834-9 | None | Diameter.long |
11835-6 | None | Diameter.long |
11836-4 | None | Diameter.long |
11837-2 | None | Diameter.long |
11838-0 | None | Diameter.long |
11839-8 | None | Diameter.long |
11840-6 | None | Diameter.long |
11841-4 | None | Diameter.long |
11842-2 | None | Diameter.long |
11843-0 | None | Diameter.long.mean |
11844-8 | None | Diameter.long.mean |
11845-5 | None | Diameter.long.mean |
11846-3 | None | Diameter.max |
11847-1 | None | Diameter.max |
11848-9 | None | Diameter.max |
11849-7 | None | Diameter.mean |
11850-5 | None | Diameter.mean |
11851-3 | None | Diameter.occipito-frontal |
11852-1 | None | Diameter.outer to outer |
11853-9 | None | Diameter.perpendicular |
11854-7 | None | Diameter.perpendicular |
11855-4 | None | Diameter.perpendicular |
11856-2 | None | Diameter.perpendicular |
11857-0 | None | Diameter.perpendicular |
11858-8 | None | Diameter.perpendicular |
11859-6 | None | Diameter.perpendicular |
11860-4 | None | Diameter.sagittal |
11861-2 | None | Diameter.sagittal.mean |
20305-9 | None | Diameter.systole |
11862-0 | None | Diameter.transverse |
11863-8 | None | Diameter.transverse |
11864-6 | None | Diameter.transverse |
11865-3 | None | Diameter.transverse |
33181-9 | None | Diameter.transverse |
52729-1 | None | Diameter.transverse |
53655-7 | None | Diameter.transverse |
53682-1 | None | Diameter.transverse |
11866-1 | None | Diameter.transverse.mean |
42704-7 | None | Diameter^baseline |
29459-5 | None | Diameter^expiration |
29429-8 | None | Diameter^inspiration |
12326-5 | Diamorphine [Presence] in Unknown substance | Diamorphine |
16198-4 | Diamorphine [Presence] in Urine by Confirm method | Diamorphine |
16754-4 | Diamorphine [Mass/volume] in Unknown substance | Diamorphine |
16755-1 | Diamorphine [Mass/volume] in Urine by Confirm method | Diamorphine |
16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirm method | Diamorphine |
18387-1 | Diamorphine [Mass/volume] in Serum or Plasma | Diamorphine |
19439-9 | Diamorphine [Presence] in Urine by Screen method | Diamorphine |
3546-9 | Diamorphine [Presence] in Urine | Diamorphine |
3547-7 | Diamorphine [Mass/volume] in Urine | Diamorphine |
4216-8 | Diamorphine [Mass] of Dose | Diamorphine |
19441-5 | Diamorphine cutoff [Mass/volume] in Urine for Screen method | Diamorphine cutoff |
19442-3 | Diamorphine cutoff [Mass/volume] in Urine for Confirm method | Diamorphine cutoff |
28089-1 | None | Diarrhea |
28379-6 | None | Diarrhea |
45622-8 | None | Diarrhea |
18033-1 | None | Diastole-systole |
18026-5 | None | Diastole.max |
18027-3 | None | Diastole.max |
18028-1 | None | Diastole.max |
18029-9 | None | Diastole.max |
20234-1 | None | Diastole.max |
20235-8 | None | Diastole.max |
20236-6 | None | Diastole.max |
20237-4 | None | Diastole.max |
20238-2 | None | Diastole.max |
18032-3 | None | Diastole.pressure half time |
12378-6 | Diazepam [Presence] in Stool | Diazepam |
14697-7 | Diazepam [Molecules/volume] in Serum or Plasma | Diazepam |
16227-1 | Diazepam [Mass/volume] in Urine by Confirm method | Diazepam |
18388-9 | Diazepam [Presence] in Urine by Confirm method | Diazepam |
19443-1 | Diazepam [Presence] in Urine by Screen method | Diazepam |
26784-9 | Diazepam [Mass/volume] in Serum or Plasma by Confirm method | Diazepam |
26837-5 | Diazepam [Mass/mass] in Hair | Diazepam |
26935-7 | Diazepam [Mass/mass] in Meconium | Diazepam |
27192-4 | Diazepam [Mass/volume] in Vitreous fluid | Diazepam |
27275-7 | Diazepam [Mass/mass] in Stool | Diazepam |
29384-5 | Diazepam [Mass/volume] in Gastric fluid | Diazepam |
3548-5 | Diazepam [Mass/volume] in Serum or Plasma | Diazepam |
3549-3 | Diazepam [Presence] in Serum or Plasma | Diazepam |
3550-1 | Diazepam [Presence] in Urine | Diazepam |
3551-9 | Diazepam [Mass/volume] in Urine | Diazepam |
35607-1 | Diazepam [Mass/volume] in Serum or Plasma by Screen method | Diazepam |
4217-6 | Diazepam [Mass] of Dose | Diazepam |
48948-4 | Diazepam [Mass/volume] in Unspecified specimen | Diazepam |
52946-1 | Diazepam [Presence] in Gastric fluid | Diazepam |
49044-1 | Diazepam & Nordiazepam panel [Mass/volume] in Serum or Plasma | Diazepam & Nordiazepam panel |
19444-9 | Diazepam cutoff [Mass/volume] in Urine for Screen method | Diazepam cutoff |
19445-6 | Diazepam cutoff [Mass/volume] in Urine for Confirm method | Diazepam cutoff |
16757-7 | Diazepam+Nordiazepam [Mass/volume] in Serum or Plasma | Diazepam+Nordiazepam |
21241-5 | Diazepam+Nordiazepam [Mass/volume] in Urine | Diazepam+Nordiazepam |
50849-9 | Diazepam+Nordiazepam [Molecules/volume] in Serum or Plasma | Diazepam+Nordiazepam |
3552-7 | Diazepam [Mass/volume] in Serum or Plasma --trough | Diazepam^trough |
35479-5 | Diazinon [Mass/volume] in Urine | Diazinon |
35488-6 | Diazinon [Mass/volume] in Serum or Plasma | Diazinon |
5638-2 | Diazinon [Mass/volume] in Blood | Diazinon |
38657-3 | Diazomethane [Mass/volume] in Air | Diazomethane |
10534-6 | Diazoxide [Mass/volume] in Serum or Plasma | Diazoxide |
3553-5 | Dibenzepin [Mass/volume] in Blood | Dibenzepin |
4218-4 | Dibenzepin [Mass] of Dose | Dibenzepin |
38760-5 | Dibenzofuran [Mass/volume] in Air | Dibenzofuran |
4219-2 | None | Dibucaine nbr |
22754-6 | None | Dibucaine number |
3554-3 | None | Dibucaine number |
16758-5 | Dicamba [Mass/volume] in Serum or Plasma | Dicamba |
16759-3 | Dicamba [Mass/volume] in Urine | Dicamba |
53214-3 | Dicarboxydodecanoylcarnitine (C12-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxydodecanoylcarnitine (C12-DC) |
53213-5 | Dicarboxydodecenoylcarnitine (C12:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxydodecenoylcarnitine (C12:1-DC) |
2206-1 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum | Dicarboxylate C6-C8-C10 |
2207-9 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine | Dicarboxylate C6-C8-C10 |
16760-1 | Dicarboxylporphyrin [Mass/volume] in Blood | Dicarboxylporphyrin |
16761-9 | Dicarboxylporphyrin [Mass/volume] in Stool | Dicarboxylporphyrin |
21242-3 | Dicarboxylporphyrin [Mass/time] in unspecified time Stool | Dicarboxylporphyrin |
18466-3 | Dicarboxyoleoylcarnitine (C18:1-DC) [Mass/volume] in Serum or Plasma | Dicarboxyoleoylcarnitine (C18:1-DC) |
53219-2 | Dicarboxyoleylcarnitine (C18:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxyoleylcarnitine (C18:1-DC) |
53217-6 | Dicarboxypalmitoleylcarnitine (C16:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxypalmitoleylcarnitine (C16:1-DC) |
53218-4 | Dicarboxypalmitoylcarnitine (C16-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxypalmitoylcarnitine (C16-DC) |
53220-0 | Dicarboxystearoylcarnitine (C18-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxystearoylcarnitine (C18-DC) |
53216-8 | Dicarboxytetradecanoylcarnitine (C14:1-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxytetradecanoylcarnitine (C14:1-DC) |
53215-0 | Dicarboxytetradecenoylcarnitine (C14-DC) [Molecules/volume] in Blood dot (filter paper) | Dicarboxytetradecenoylcarnitine (C14-DC) |
16762-7 | Dichlorobenzene [Mass/volume] in Blood | Dichlorobenzene |
38315-8 | Dichlorobenzene [Mass/volume] in Water | Dichlorobenzene |
10911-6 | Dichlorobenzidine [Mass/volume] in Urine | Dichlorobenzidine |
38663-1 | Dichlorobenzidine [Mass/volume] in Air | Dichlorobenzidine |
12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood | Dichlorodifluoroethane |
13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood | Dichlorodifluoromethane |
11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma | Dichlorodiphenyldichloroethylene |
14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue | Dichlorodiphenyldichloroethylene |
16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine | Dichlorodiphenyldichloroethylene |
16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood | Dichlorodiphenyldichloroethylene |
38669-8 | Dichlorodiphenyldichloroethylene [Mass/volume] in Air | Dichlorodiphenyldichloroethylene |
11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma | Dichlorodiphenyltrichloroethane |
14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue | Dichlorodiphenyltrichloroethane |
16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk | Dichlorodiphenyltrichloroethane |
26953-0 | Dichlorodiphenyltrichloroethane [Presence] in Serum or Plasma | Dichlorodiphenyltrichloroethane |
38340-6 | None | Dichlorodiphenyltrichloroethane |
53643-3 | Dichlorodiphenyltrichloroethane [Presence] in Gastric fluid | Dichlorodiphenyltrichloroethane |
12307-5 | Dichloroethane [Mass/volume] in Blood | Dichloroethane |
16766-8 | Dichloroethane [Presence] in Blood | Dichloroethane |
38316-6 | Dichloroethane [Mass/volume] in Water | Dichloroethane |
3555-0 | Dichlorphenamide [Presence] in Urine | Dichlorphenamide |
3556-8 | Dichlorphenamide [Mass/volume] in Urine | Dichlorphenamide |
3557-6 | Dichlorphenamide [Mass/time] in 24 hour Urine | Dichlorphenamide |
4220-0 | Dichlorphenamide [Mass] of Dose | Dichlorphenamide |
16768-4 | Dichlorvos [Mass/volume] in Urine | Dichlorvos |
30026-9 | Dichlorvos [Mass/volume] in Serum or Plasma | Dichlorvos |
38591-4 | Dichlorvos [Mass/volume] in Air | Dichlorvos |
9515-8 | Diclofenac [Mass/volume] in Serum or Plasma | Diclofenac |
48274-5 | Diclofenac triggered leukotriene release [Mass/volume] by Leukocytes | Diclofenac leukotriene release |
10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma | Dicloxacillin |
16769-2 | Dicloxacillin [Mass/volume] in Urine | Dicloxacillin |
18916-7 | Dicloxacillin [Susceptibility] | Dicloxacillin |
220-4 | Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC) | Dicloxacillin |
221-2 | Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dicloxacillin |
222-0 | Dicloxacillin [Susceptibility] by Disk diffusion (KB) | Dicloxacillin |
223-8 | Dicloxacillin [Susceptibility] by Serum bactericidal titer | Dicloxacillin |
25252-8 | Dicloxacillin [Mass/volume] in Unspecified specimen | Dicloxacillin |
32380-8 | None | Dicloxacillin |
16770-0 | Dicoumarol [Mass/volume] in Urine | Dicoumarol |
3558-4 | Dicoumarol [Mass/volume] in Serum or Plasma | Dicoumarol |
11489-2 | Provider, dictating practitioner - identifier | Dictating practitioner ID |
18770-8 | Provider, dictating practitioner - name | Dictating practitioner name |
16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma | Dicyclomine |
45630-1 | None | Did not use toilet room &or commode &or urinal |
29116-1 | Didanosine [Units/volume] in Serum or Plasma | Didanosine |
30270-3 | Didanosine [Susceptibility] by Phenotype method | Didanosine |
30284-4 | Didanosine [Susceptibility] by Genotype method | Didanosine |
30300-8 | Didanosine [Susceptibility] | Didanosine |
48307-3 | Didanosine [Mass/volume] in Serum or Plasma | Didanosine |
26042-2 | Didesmethylcitalopram [Molecules/volume] in Serum or Plasma | Didesmethylcitalopram |
11095-7 | Dieldrin [Mass/volume] in Serum or Plasma | Dieldrin |
16772-6 | Dieldrin [Mass/volume] in Urine | Dieldrin |
16773-4 | Dieldrin [Mass/volume] in Blood | Dieldrin |
45746-5 | None | Dietary supplement between meals |
38665-6 | Diethanolamine [Mass/volume] in Air | Diethanolamine |
13936-0 | Diethyl ether [Mass/volume] in Blood | Diethyl ether |
21243-1 | Diethyl ether [Mass/volume] in Urine | Diethyl ether |
2208-7 | Diethyl ether [Mass/volume] in Serum or Plasma | Diethyl ether |
27001-7 | Diethyl ether [Presence] in Blood | Diethyl ether |
16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma | Diethylcarbamazepine |
41474-8 | Diethylcarbamazepine [Mass/volume] in Blood dot (filter paper) | Diethylcarbamazepine |
34436-6 | Diethylene glycol [Mass/volume] in Serum or Plasma | Diethylene glycol |
16210-7 | Diethylpropion [Presence] in Urine by Confirm method | Diethylpropion |
16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma | Diethylpropion |
21244-9 | None | Diethylpropion |
3345-6 | Diethylpropion [Presence] in Urine | Diethylpropion |
3346-4 | Diethylpropion [Mass/volume] in Urine | Diethylpropion |
3347-2 | Diethylpropion [Mass/time] in 24 hour Urine | Diethylpropion |
4124-4 | Diethylpropion [Mass] of Dose | Diethylpropion |
14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma | Diethylstilbestrol |
38666-4 | Diethylsulfate [Mass/volume] in Air | Diethylsulfate |
45615-2 | None | Difference in ADL Self-Performance or ADL Support, comparing mornings to evenings |
49024-3 | Differential cell count method [Type] in Blood | Differential cell count method |
24318-8 | Differential panel in Blood | Differential panel |
29580-8 | Differential panel in Body fluid | Differential panel |
29581-6 | Differential panel in Peritoneal fluid | Differential panel |
29582-4 | Differential panel in Synovial fluid | Differential panel |
29583-2 | Differential panel in Pleural fluid | Differential panel |
29584-0 | Differential panel in Cerebral spinal fluid | Differential panel |
47286-0 | Differential panel in Bone marrow | Differential panel |
28380-4 | None | Difficulty concentrating |
19910-9 | None | Diffusion capacity.carbon monoxide |
19911-7 | None | Diffusion capacity.carbon monoxide |
19912-5 | None | Diffusion capacity.carbon monoxide^^adjusted for hemoglobin |
19913-3 | None | Diffusion capacity.carbon monoxide^^adjusted for hemoglobin |
19914-1 | None | Diffusion capacity/Alveolar volume |
19915-8 | None | Diffusion capacity/Alveolar volume |
19916-6 | None | Diffusion capacity/Alveolar volume |
19917-4 | None | Diffusion capacity^^adjusted to body conditions |
19918-2 | None | Diffusion capacity^^adjusted to body conditions |
35790-5 | Difloxacin [Susceptibility] by Disk diffusion (KB) | Difloxacin |
35791-3 | Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Difloxacin |
35792-1 | Difloxacin [Susceptibility] | Difloxacin |
14065-7 | Diflunisal [Mass/volume] in Serum or Plasma | Diflunisal |
28269-9 | None | Digestion-hydration.behavior |
28483-6 | None | Digestion-hydration.behavior |
46807-4 | None | Digestion-hydration.behavior |
28270-7 | None | Digestion-hydration.knowledge |
28484-4 | None | Digestion-hydration.knowledge |
46808-2 | None | Digestion-hydration.knowledge |
28271-5 | None | Digestion-hydration.status |
28485-1 | None | Digestion-hydration.status |
46809-0 | None | Digestion-hydration.status |
15104-3 | Digitoxin [Molecules/volume] in Serum or Plasma | Digitoxin |
29215-1 | Digitoxin [Mass/volume] in Body fluid | Digitoxin |
3559-2 | Digitoxin [Mass/volume] in Serum or Plasma | Digitoxin |
3560-0 | Digitoxin [Mass/volume] in Urine | Digitoxin |
4221-8 | Digitoxin [Mass] of Dose | Digitoxin |
3561-8 | Digitoxin>6h post dose [Mass/volume] in Serum or Plasma | Digitoxin>6h post dose |
10535-3 | Digoxin [Mass/volume] in Serum or Plasma | Digoxin |
14698-5 | Digoxin [Molecules/volume] in Serum or Plasma | Digoxin |
29216-9 | Digoxin [Mass/volume] in Body fluid | Digoxin |
35244-3 | Digoxin [Mass or Molecules/volume] in Serum or Plasma | Digoxin |
4222-6 | Digoxin [Mass] of Dose | Digoxin |
32067-1 | Digoxin Free [Molecules/volume] in Serum or Plasma | Digoxin.free |
3562-6 | Digoxin Free [Mass/volume] in Serum or Plasma | Digoxin.free |
3563-4 | Digoxin>12h post dose [Mass/volume] in Serum or Plasma | Digoxin>12h post dose |
48370-1 | Dihomogammalinolenate (C20:3n-6) [Molecules/volume] in Serum or Plasma | Dihomogammalinolenate |
14066-5 | Dihydrocodeine [Presence] in Urine | Dihydrocodeine |
14067-3 | Dihydrocodeine [Mass/volume] in Blood | Dihydrocodeine |
16211-5 | Dihydrocodeine [Presence] in Urine by Confirm method | Dihydrocodeine |
19446-4 | Dihydrocodeine [Presence] in Urine by Screen method | Dihydrocodeine |
19448-0 | Dihydrocodeine [Mass/volume] in Urine by Confirm method | Dihydrocodeine |
19449-8 | Dihydrocodeine [Mass/volume] in Urine | Dihydrocodeine |
42901-9 | Dihydrocodeine [Mass/volume] in Serum or Plasma | Dihydrocodeine |
19450-6 | Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method | Dihydrocodeine cutoff |
19451-4 | Dihydrocodeine cutoff [Mass/volume] in Urine for Confirm method | Dihydrocodeine cutoff |
27035-5 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium | Dihydrocodeine+Hydrocodeinone |
28072-7 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool | Dihydrocodeine+Hydrocodeinone |
46257-2 | Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method | Dihydrocodeine+Hydrocodol |
51448-9 | Dihydrocodeine+Hydrocodol [Mass/volume] in Urine | Dihydrocodeine+Hydrocodol |
51765-6 | Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma | Dihydrocodeine+Hydrocodol |
12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma | Dihydrocodeine.free |
16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirm method | Dihydrocodeine.free |
46703-5 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method | Dihydrocodeine.free+Hydrocodol.free |
46704-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method | Dihydrocodeine.free+Hydrocodol.free |
49750-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma | Dihydrocodeine.free+Hydrocodol.free |
51955-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine | Dihydrocodeine.free+Hydrocodol.free |
2209-5 | Dihydrofolate [Mass/volume] in Serum | Dihydrofolate |
2210-3 | Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue | Dihydrolipoamide acetyl transferase |
2211-1 | Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue | Dihydrolipoamide dehydrogenase |
2212-9 | Dihydropteridine reductase [Enzymatic activity/volume] in Serum | Dihydropteridine reductase |
24081-2 | Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast | Dihydroxyacetone phosphate acylcoa acyl transferase |
53479-2 | Dihydroxycholestanoate [Molecules/volume] in Serum or Plasma | Dihydroxycholestanoate |
13015-3 | Diisobutylketone [Mass/volume] in Blood | Diisobutylketone |
21245-6 | Diisobutylketone [Mass/volume] in Urine | Diisobutylketone |
16776-7 | Diltiazem [Mass/volume] in Urine | Diltiazem |
6898-1 | Diltiazem [Mass/volume] in Serum or Plasma | Diltiazem |
53977-5 | Dimagnesium phosphate crystals [Presence] in Urine sediment by Light microscopy | Dimagnesium phosphate crystals |
12365-3 | Dimenhydrinate [Presence] in Urine | Dimenhydrinate |
12391-9 | Dimenhydrinate [Mass/volume] in Serum or Plasma | Dimenhydrinate |
39475-9 | Dimenhydrinate [Molecules/volume] in Serum or Plasma | Dimenhydrinate |
19452-2 | Dimetamphetamine [Presence] in Urine by Screen method | Dimetamphetamine |
19453-0 | Dimetamphetamine [Presence] in Urine by Confirm method | Dimetamphetamine |
20526-0 | Dimetamphetamine [Mass/volume] in Urine by Confirm method | Dimetamphetamine |
3564-2 | Dimetamphetamine [Presence] in Urine | Dimetamphetamine |
3565-9 | Dimetamphetamine [Mass/volume] in Urine | Dimetamphetamine |
3566-7 | Dimetamphetamine [Mass/time] in 24 hour Urine | Dimetamphetamine |
19454-8 | Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method | Dimetamphetamine cutoff |
19455-5 | Dimetamphetamine cutoff [Mass/volume] in Urine for Confirm method | Dimetamphetamine cutoff |
2213-7 | Dimethadione [Mass/volume] in Serum or Plasma | Dimethadione |
21246-4 | Dimethoate [Mass/volume] in Urine | Dimethoate |
30027-7 | Dimethoate [Mass/volume] in Serum or Plasma | Dimethoate |
38689-6 | Dimethyl sulfate [Mass/volume] in Air | Dimethyl sulfate |
12372-9 | Dimethylacetamide [Mass/volume] in Urine | Dimethylacetamide |
16777-5 | Dimethylacetamide [Presence] in Urine | Dimethylacetamide |
38668-0 | Dimethylaniline [Mass/volume] in Air | Dimethylaniline |
13940-2 | Dimethylbenzene [Mass/volume] in Blood | Dimethylbenzene |
17772-5 | Dimethylbenzene [Mass/volume] in Urine | Dimethylbenzene |
29296-1 | Dimethylbenzene [Presence] in Blood | Dimethylbenzene |
38755-5 | Dimethylbenzene [Mass/volume] in Air | Dimethylbenzene |
5758-8 | None | Dimethylbenzene |
5759-6 | Dimethylbenzene [Mass/volume] in Serum or Plasma | Dimethylbenzene |
13832-1 | Dimethylbenzene/Creatinine [Mass ratio] in Urine | Dimethylbenzene/Creatinine |
38740-7 | Dimethylcarbamoyl chloride [Mass/volume] in Air | Dimethylcarbamoyl chloride |
38592-2 | Dimethylformamide [Mass/volume] in Air | Dimethylformamide |
23853-5 | Dimethylformamide/Creatinine [Mass ratio] in Urine | Dimethylformamide/Creatinine |
49837-8 | Dimethylphosphatidyl ethanolamine/Surfactant.total in Amniotic Fluid | Dimethylphosphatidyl ethanolamine/Surfactant.total |
38673-0 | Dimethylphthalate [Mass/volume] in Air | Dimethylphthalate |
12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma | Dimethylsulfoxide |
14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma | Dimethylsulfoxide |
12292-9 | Dimethyltryptamine [Presence] in Urine | Dimethyltryptamine |
3567-5 | Dimethyltryptamine [Mass/volume] in Serum or Plasma | Dimethyltryptamine |
3568-3 | Dimethyltryptamine [Mass/volume] in Urine | Dimethyltryptamine |
2214-5 | Dinitrobenzene [Mass/volume] in Urine | Dinitrobenzene |
16778-3 | Dinitrophenol [Presence] in Serum or Plasma | Dinitrophenol |
16779-1 | Dinitrophenol [Mass/volume] in Urine | Dinitrophenol |
10661-7 | Dinoflagelate identified in Water by Light microscopy | Dinoflagelate identified |
38298-6 | Dinoseb [Mass/volume] in Water | Dinoseb |
7782-6 | Yam IgE Ab [Units/volume] in Serum | Dioscorea batatas Ab.IgE |
10947-0 | Persimmon IgE Ab [Units/volume] in Serum | Diospyros kaki Ab.IgE |
29862-0 | Persimmon IgE Ab RAST class in Serum | Diospyros kaki Ab.IgE.RAST class |
23854-3 | Dioxin [Mass/volume] in Serum or Plasma | Dioxin |
27316-9 | Dioxin [Presence] in Serum or Plasma | Dioxin |
38299-4 | Dioxin [Mass/volume] in Water | Dioxin |
38619-3 | Dioxin [Mass/volume] in Air | Dioxin |
2215-2 | Dipalmitoylphosphatidylcholine [Mass/volume] in Serum | Dipalmitoylphosphatidylcholine |
29531-1 | Diphenhydramine [Presence] in Unspecified specimen | Diphenhydramine |
35608-9 | Diphenhydramine [Mass/volume] in Serum or Plasma by Screen method | Diphenhydramine |
3569-1 | Diphenhydramine [Presence] in Serum or Plasma | Diphenhydramine |
3570-9 | Diphenhydramine [Mass/volume] in Serum or Plasma | Diphenhydramine |
3571-7 | Diphenhydramine [Presence] in Urine | Diphenhydramine |
3572-5 | Diphenhydramine [Mass/volume] in Urine | Diphenhydramine |
39476-7 | Diphenhydramine [Molecules/volume] in Serum or Plasma | Diphenhydramine |
4224-2 | Diphenhydramine [Mass] of Dose | Diphenhydramine |
14699-3 | Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid | Diphenhydramine+Dimenhydrinate |
14700-9 | Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma | Diphenhydramine+Dimenhydrinate |
14701-7 | Diphenhydramine+Dimenhydrinate [Presence] in Urine | Diphenhydramine+Dimenhydrinate |
32068-9 | Diphenhydramine+Dimenhydrinate [Presence] in Unspecified specimen | Diphenhydramine+Dimenhydrinate |
12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma | Diphenoxylate |
4226-7 | None | Diphenylhydramine |
33335-1 | Diphenylmethoxyacetate [Presence] in Urine by Screen method | Diphenylmethoxyacetate |
11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells | Diphosphoglycerate mutase |
47853-7 | Diphosphoglycerate phosphatase [Enzymatic activity/mass] in Red Blood Cells | Diphosphoglycerate phosphatase |
14479-0 | Diphtheria identified in Throat by Organism specific culture | Diphtheria sp identified |
14480-8 | Diphtheria identified in Sputum by Organism specific culture | Diphtheria sp identified |
14481-6 | Diphtheria identified in Nose by Organism specific culture | Diphtheria sp identified |
14482-4 | Diphtheria identified in Skin by Organism specific culture | Diphtheria sp identified |
14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture | Diphtheria sp identified |
567-8 | Diphtheria identified in Unspecified specimen by Organism specific culture | Diphtheria sp identified |
6596-1 | Diphtheria identified in Isolate by Organism specific culture | Diphtheria sp identified |
3573-3 | Dipipanone [Presence] in Urine | Dipipanone |
3574-1 | Dipipanone [Mass/volume] in Urine | Dipipanone |
3575-8 | Dipipanone [Mass/time] in 24 hour Urine | Dipipanone |
4227-5 | Dipipanone [Mass] of Dose | Dipipanone |
10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma | Dipyridamole |
9748-5 | Dipyridamole [Mass/volume] in Unspecified specimen | Dipyridamole |
48783-5 | Dipyrone IgE Ab [Units/volume] in Serum | Dipyrone Ab.IgE |
48782-7 | Dipyrone IgE Ab RAST class in Serum | Dipyrone Ab.IgE.RAST class |
48280-2 | Dipyrone triggered leukotriene release [Mass/volume] by Leukocytes | Dipyrone leukotriene release |
12339-8 | Diquat [Presence] in Urine | Diquat |
38300-0 | Diquat [Mass/volume] in Water | Diquat |
35521-4 | None | Direct access to source data+documents section |
1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | Direct antiglobulin test.complement specific reagent |
53744-9 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells by 5 minute RT incubation | Direct antiglobulin test.complement specific reagent |
1006-6 | Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells | Direct antiglobulin test.IgG specific reagent |
52114-6 | Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells | Direct antiglobulin test.IgG specific reagent |
1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | Direct antiglobulin test.poly specific reagent |
1009-0 | None | Direct antiglobulin test.poly specific reagent |
51871-2 | Direct antiglobulin test.poly specific reagent [presence] on Cord red blood cells | Direct antiglobulin test.poly specific reagent |
46274-7 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --post transfusion reaction | Direct antiglobulin test.poly specific reagent^post transfusion reaction |
51006-5 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells | Direct antiglobulin test.XXX reagent |
51007-3 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells --post transfusion | Direct antiglobulin test.XXX reagent^post transfusion |
45613-7 | None | Direct care staff believe resident is capable of increased independence in at least some ADLs |
35793-9 | Dirithromycin [Susceptibility] by Disk diffusion (KB) | Dirithromycin |
35794-7 | Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Dirithromycin |
35795-4 | Dirithromycin [Susceptibility] | Dirithromycin |
7007-8 | Dirithromycin [Susceptibility] by Gradient strip (E-test) | Dirithromycin |
30040-0 | Dirofilaria immitis Ab [Units/volume] in Serum | Dirofilaria immitis Ab |
30044-2 | Dirofilaria immitis Ab [Titer] in Serum | Dirofilaria immitis Ab |
23029-2 | Dirofilaria immitis Ag [Presence] in Blood | Dirofilaria immitis Ag |
23710-7 | Dirofilaria immitis Ag [Presence] in Serum by Immunoassay | Dirofilaria immitis Ag |
31801-4 | Dirofilaria immitis Ag [Presence] in Serum | Dirofilaria immitis Ag |
28090-9 | None | Disabled family coping |
7282-7 | Discase IgE Ab [Units/volume] in Serum | Discase Ab.IgE |
28622-9 | Nurse hospital discharge assessment | Discharge assessment note |
52525-3 | None | Discharge date |
42344-2 | None | Discharge diet |
46579-9 | None | Discharge disposition |
42345-9 | None | Discharge functional status |
28574-2 | Provider-unspecified hospital discharge summary | Discharge note |
46069-1 | None | Discharge potential |
46068-3 | None | Discharge potential and overall status section |
11490-0 | Physician hospital discharge summary | Discharge summarization note |
18842-5 | Hospital discharge history (narrative) | Discharge summarization note |
28655-9 | Attending physician discharge summary | Discharge summarization note |
29761-4 | Dentist hospital discharge summary | Discharge summarization note |
34105-7 | None | Discharge summarization note |
34106-5 | None | Discharge summarization note |
34745-0 | None | Discharge summarization note |
46475-0 | None | Discharge support services or assistance |
46582-3 | None | Discharge, transfer, death date |
18593-4 | Ambulance transport, discharged from originating facility on transfer | Discharged from origin institution |
46500-5 | None | Discipline of person completing assessment |
46018-8 | None | Disease or condition diagnoses section |
46152-5 | None | Diseases (quarterly RUG-III 97 update) |
46150-9 | None | Diseases (quarterly RUG-III) |
54117-7 | None | Diseases history panel |
54137-5 | None | Diseases history panel |
46019-6 | None | Diseases or conditions |
13107-8 | None | Disialylganglioside GD1a Ab |
31344-5 | Disialylganglioside GD1a Ab [Units/volume] in Serum | Disialylganglioside GD1a Ab |
44740-9 | Disialylganglioside GD1a Ab [Presence] in Serum | Disialylganglioside GD1a Ab |
40819-5 | Disialylganglioside GD1a IgM Ab [Units/volume] in Serum | Disialylganglioside GD1a Ab.IgM |
13102-9 | None | Disialylganglioside GD1b Ab |
13109-4 | None | Disialylganglioside GD1b Ab |
31345-2 | Disialylganglioside GD1b Ab [Units/volume] in Serum | Disialylganglioside GD1b Ab |
39586-3 | Disialylganglioside GD1b Ab [Titer] in Serum | Disialylganglioside GD1b Ab |
44741-7 | Disialylganglioside GD1b Ab [Presence] in Serum | Disialylganglioside GD1b Ab |
13103-7 | None | Disialylganglioside GD1b Ab.IgG |
30329-7 | Disialylganglioside GD1b IgG Ab [Titer] in Serum | Disialylganglioside GD1b Ab.IgG |
31346-0 | Disialylganglioside GD1b IgG Ab [Units/volume] in Serum | Disialylganglioside GD1b Ab.IgG |
44742-5 | Disialylganglioside GD1b IgG Ab [Presence] in Serum | Disialylganglioside GD1b Ab.IgG |
13104-5 | None | Disialylganglioside GD1b Ab.IgM |
30330-5 | Disialylganglioside GD1b IgM Ab [Titer] in Serum | Disialylganglioside GD1b Ab.IgM |
31347-8 | Disialylganglioside GD1b IgM Ab [Units/volume] in Serum | Disialylganglioside GD1b Ab.IgM |
44743-3 | Disialylganglioside GD1b IgM Ab [Presence] in Serum | Disialylganglioside GD1b Ab.IgM |
12366-1 | Disopyramide [Presence] in Urine | Disopyramide |
13558-2 | Disopyramide [Presence] in Serum or Plasma | Disopyramide |
14702-5 | Disopyramide [Molecules/volume] in Serum or Plasma | Disopyramide |
16780-9 | Disopyramide [Mass/volume] in Urine | Disopyramide |
29217-7 | Disopyramide [Mass/volume] in Body fluid | Disopyramide |
29401-7 | Disopyramide [Mass/volume] in Gastric fluid | Disopyramide |
3576-6 | Disopyramide [Mass/volume] in Serum or Plasma | Disopyramide |
4228-3 | Disopyramide [Mass] of Dose | Disopyramide |
28381-2 | None | Disorientation |
28868-8 | None | Dispenser code |
28869-6 | None | Dispenser text |
43165-0 | Dissolved solids [Mass/volume] in Water | Dissolved solids |
51996-7 | Ambulance transport, distance and time transported information (composite) | Distance and time transported information |
28734-2 | None | Distance comment |
28735-9 | None | Distance comment |
33748-5 | None | Distance from anal verge |
33749-3 | None | Distance from anal verge unknown |
28848-0 | None | Distance N.binocular |
33752-7 | None | Distance of carcinoma from closest lateral margin |
33755-0 | None | Distance of carcinoma from deep margin |
44685-6 | None | Distance of invasive melanoma to closest deep margin |
44683-1 | None | Distance of invasive melanoma to closest lateral margin |
44684-9 | None | Distance of melanoma in situ to closest lateral margin |
33737-8 | None | Distance of tumor from closest margin |
28738-3 | None | Distance signs |
28739-1 | None | Distance signs |
28740-9 | None | Distance signs.binocular |
15510-1 | Ambulance transport, distance transported | Distance transported |
51997-5 | Ambulance transport, distance and time transported information - loaded indicator | Distance transported - loaded indicator |
21907-1 | None | Distant metastases.clinical |
21913-9 | None | Distant metastases.other |
21901-4 | None | Distant metastases.pathology |
44667-4 | None | Distant metastasis site |
6238-0 | Salt grass IgE Ab [Units/volume] in Serum | Distichlis spicata Ab.IgE |
15752-9 | Salt grass IgE Ab RAST class in Serum | Distichlis spicata Ab.IgE.RAST class |
45436-3 | None | Distinct food preferences |
52864-6 | None | District catchment area |
45230-0 | None | District where patient entered HIV Rx |
16781-7 | Disulfiram [Presence] in Urine | Disulfiram |
3577-4 | Disulfiram [Mass/volume] in Serum or Plasma | Disulfiram |
4229-1 | Disulfiram [Mass] of Dose | Disulfiram |
9357-5 | Disulfiram [Mass/volume] in Urine | Disulfiram |
28091-7 | None | Disuse syndrome |
12288-7 | Diuretics [Identifier] in Urine | Diuretics |
32010-1 | Diuretics [Identifier] in Serum or Plasma by Screen method | Diuretics |
32676-9 | Diuretics [Mass/volume] in Urine | Diuretics |
28092-5 | None | Diversional activity deficit |
45699-6 | None | Dizziness or vertigo |
21247-2 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DMD gene mutation analysis |
50626-1 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DMD gene mutation analysis |
22075-6 | DMD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | DMD gene mutations tested for |
35375-5 | DMPK gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method | DMPK gene allele 1 |
35751-7 | DMPK gene allele 1 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | DMPK gene allele 1.CTG repeats |
35374-8 | DMPK gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method | DMPK gene allele 2 |
35750-9 | DMPK gene allele 2 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | DMPK gene allele 2.CTG repeats |
34727-8 | DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DMPK gene mutation analysis |
21757-0 | DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method | DMPK gene.CTG repeats |
35749-1 | DMPK phenotype [Type] in Blood or Tissue by Molecular genetics method | DMPK phenotype |
13308-2 | None | DNA |
11013-0 | DNA double strand Ab [Titer] in Serum | DNA double strand Ab |
11563-4 | None | DNA double strand Ab |
12277-0 | DNA double strand Ab [Presence] in Serum by Farr method | DNA double strand Ab |
15177-9 | DNA double strand Ab [Units/volume] in Body fluid | DNA double strand Ab |
16782-5 | None | DNA double strand Ab |
31348-6 | DNA double strand Ab [Presence] in Serum | DNA double strand Ab |
32677-7 | DNA double strand Ab [Units/volume] in Serum by Immunoassay | DNA double strand Ab |
34187-5 | DNA double strand Ab [Titer] in Serum by IF Crithidia luciliae | DNA double strand Ab |
37993-3 | DNA double strand Ab [Mass/volume] in Serum by Radioimmunoassay (RIA) | DNA double strand Ab |
42200-6 | DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | DNA double strand Ab |
47299-3 | DNA double strand Ab [Units/volume] in Serum by Farr method | DNA double strand Ab |
48308-1 | DNA double strand Ab [Units/volume] in Body fluid by Farr method | DNA double strand Ab |
5130-0 | DNA double strand Ab [Units/volume] in Serum | DNA double strand Ab |
5131-8 | DNA double strand Ab [Presence] in Serum by Immunofluorescence | DNA double strand Ab |
53148-3 | DNA double strand Ab [Presence] in Body fluid | DNA double strand Ab |
6457-6 | DNA double strand Ab [Presence] in Serum by IF Crithidia luciliae | DNA double strand Ab |
33799-8 | DNA double strand IgG Ab [Units/volume] in Serum by Immunoassay | DNA double strand Ab.IgG |
33800-4 | DNA double strand IgG Ab [Units/volume] in Serum | DNA double strand Ab.IgG |
30912-0 | DNA index in Unspecified specimen by Flow cytometry (FC) | DNA index |
34975-3 | DNA index in Serum or Plasma by Flow cytometry (FC) | DNA index |
34973-8 | DNA index 2 in Serum or Plasma by Flow cytometry (FC) | DNA index 2 |
34976-1 | DNA index 2 in Unspecified specimen by Flow cytometry (FC) | DNA index 2 |
34972-0 | DNA index 3 in Unspecified specimen by Flow cytometry (FC) | DNA index 3 |
34974-6 | DNA index 3 in Serum or Plasma by Flow cytometry (FC) | DNA index 3 |
48004-6 | DNA marker [Finding] in Blood or Tissue by Molecular genetics method | DNA marker |
53043-6 | DNA marker analysis test coverage panel in Blood or Tissue by Molecular genetics method | DNA marker analysis test coverage panel |
53035-2 | DNA marker assessed [Identifier] in Blood or Tissue by Molecular genetics method | DNA marker assessed |
53042-8 | DNA marker assessed panel in Blood or Tissue by Molecular genetics method | DNA marker assessed panel |
53044-4 | DNA marker identified panel in Blood or Tissue by Molecular genetics method | DNA marker identified panel |
48003-8 | DNA marker identifier [Identifier] in Blood or Tissue by Molecular genetics method | DNA marker identifier |
47998-0 | DNA marker interpretation short name [Text] in Blood or Tissue by Molecular genetics method Narrative | DNA marker interpretation short name |
51960-3 | DNA marker results panel in Blood or Tissue by Molecular genetics method | DNA marker results panel |
48019-4 | DNA marker type in Blood or Tissue by Molecular genetics method | DNA marker type |
30911-2 | DNA ploidy [Identifier] in Unspecified specimen by Flow cytometry (FC) Nominal | DNA ploidy |
30917-9 | DNA ploidy [interpretation] in Unspecified specimen by Flow cytometry (FC) Narrative | DNA ploidy |
51956-1 | DNA region analysis test coverage panel in Blood or Tissue by Molecular genetics method | DNA region analysis test coverage panel |
47999-8 | DNA region name [Identifier] in Blood or Tissue by Molecular genetics method | DNA region name |
51959-5 | DNA region of interest [Identifier] in Blood or Tissue by Molecular genetics method | DNA region of interest |
53041-0 | DNA region of interest panel in Blood or Tissue by Molecular genetics method | DNA region of interest panel |
5132-6 | DNA single strand Ab [Units/volume] in Serum | DNA single strand Ab |
10360-6 | DNA single strand IgG Ab [Units/volume] in Serum | DNA single strand Ab.IgG |
42201-4 | DNA single strand IgG Ab [Units/volume] in Serum by Immunoassay | DNA single strand Ab.IgG |
10361-4 | DNA single strand IgM Ab [Units/volume] in Serum | DNA single strand Ab.IgM |
53855-3 | DNAI1+DNAH5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DNAI1+DNAH5 gene mutation analysis |
14207-5 | Streptococcal DNAse B [Titer] in Serum | DNAse B Ab.Streptococcal |
5133-4 | Streptococcal DNAse B [Units/volume] in Serum | DNAse B Ab.Streptococcal |
48538-3 | None | Do you enjoy getting up in the morning |
48532-6 | None | Do you feel full of energy |
48520-1 | None | Do you feel happy most of the time |
48528-4 | None | Do you feel pretty worthless the way you are now |
48514-4 | None | Do you feel that your life is empty |
48533-4 | None | Do you feel that your situation is hopeless |
48525-0 | None | Do you feel you have more problems with memory than most |
48530-0 | None | Do you find life very exciting |
48536-7 | None | Do you frequently feel like crying |
48535-9 | None | Do you frequently get upset over little things |
48524-3 | None | Do you frequently worry about the future |
48537-5 | None | Do you have trouble concentrating |
48527-6 | None | Do you often feel downhearted and blue |
48521-9 | None | Do you often feel helpless |
48515-1 | None | Do you often get bored |
48522-7 | None | Do you often get restless and fidgety |
48539-1 | None | Do you prefer to avoid social gatherings |
48523-5 | None | Do you prefer to stay at home, rather than going out and doing new things |
48526-8 | None | Do you think it is wonderful to be alive now |
48534-2 | None | Do you think that most people are better off than you are |
48529-2 | None | Do you worry a lot about the past |
21248-0 | Dobutamine [Mass/volume] in Serum or Plasma | Dobutamine |
35174-2 | Docosahexaenoate (C22:6w3) [Molecules/volume] in Serum or Plasma | Docosahexaenoate |
35180-9 | Docosapentaenate (C22:5w3) [Molecules/volume] in Serum or Plasma | Docosapentaenate w3 |
35181-7 | Docosapentaenate (C22:5w6) [Molecules/volume] in Serum or Plasma | Docosapentaenate w6 |
48371-9 | Docosapentaenoate (C22:5 n-3) [Molecules/volume] in Serum or Plasma | Docosapentaenoate |
35182-5 | Docosatetraenoate (C22:4w6) [Molecules/volume] in Serum or Plasma | Docosatetraenoate |
35160-1 | Docosenoate (C22:1) [Molecules/volume] in Serum or Plasma | Docosenoate |
53109-5 | Docosenoate (C22:1)/Creatinine [Molecular ratio] in Urine | Docosenoate/Creatinine |
13732-3 | Dodecanedioate/Creatinine [Mass ratio] in Urine | Dodecanedioate/Creatinine |
25097-7 | Dodecanedioate/Creatinine [Molecular ratio] in Urine | Dodecanedioate/Creatinine |
18455-6 | Dodecanoylcarnitine (C12) [Mass/volume] in Serum or Plasma | Dodecanoylcarnitine (C12) |
30331-3 | Dodecanoylcarnitine (C12) [Molecules/volume] in Serum or Plasma | Dodecanoylcarnitine (C12) |
45199-7 | Dodecanoylcarnitine (C12) [Molecules/volume] in Blood dot (filter paper) | Dodecanoylcarnitine (C12) |
53058-4 | Dodecanoylcarnitine (C12) [Molecules/volume] in Amniotic Fluid | Dodecanoylcarnitine (C12) |
53078-2 | Dodecanoylcarnitine (C12) [Molecules/volume] in Cerebral spinal fluid | Dodecanoylcarnitine (C12) |
53510-4 | Dodecanoylcarnitine (C12)/Creatinine [Molecular ratio] in Urine | Dodecanoylcarnitine (C12)/Creatinine |
49939-2 | Dodecenedioate/Creatinine [Molecular ratio] in Urine | Dodecenedioate/Creatinine |
18454-9 | Dodecenoylcarnitine (C12:1) [Mass/volume] in Serum or Plasma | Dodecenoylcarnitine (C12:1) |
30332-1 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Serum or Plasma | Dodecenoylcarnitine (C12:1) |
45200-3 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Blood dot (filter paper) | Dodecenoylcarnitine (C12:1) |
53059-2 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Amniotic Fluid | Dodecenoylcarnitine (C12:1) |
53079-0 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Cerebral spinal fluid | Dodecenoylcarnitine (C12:1) |
53104-6 | Dodecenoylcarnitine (C12:1) [Molecules/volume] in Urine | Dodecenoylcarnitine (C12:1) |
53511-2 | Dodecenoylcarnitine (C12:1)/Creatinine [Molecular ratio] in Urine | Dodecenoylcarnitine (C12:1)/Creatinine |
53542-7 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Amniotic Fluid | Dodeicosanoylcarnitine (C22) |
53543-5 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Blood dot (filter paper) | Dodeicosanoylcarnitine (C22) |
53545-0 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Cerebral spinal fluid | Dodeicosanoylcarnitine (C22) |
53546-8 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Serum or Plasma | Dodeicosanoylcarnitine (C22) |
53549-2 | Dodeicosanoylcarnitine (C22) [Molecules/volume] in Urine | Dodeicosanoylcarnitine (C22) |
53552-6 | Dodeicosanoylcarnitine (C22)/Creatinine [Molecular ratio] in Urine | Dodeicosanoylcarnitine (C22)/Creatinine |
45582-4 | None | Does not adjust easily to change in routines |
6098-8 | Dog dander IgE Ab [Units/volume] in Serum | Dog dander Ab.IgE |
15685-1 | Dog dander IgE Ab RAST class in Serum | Dog dander Ab.IgE.RAST class |
7284-3 | Dog dander IgG Ab [Units/volume] in Serum | Dog dander Ab.IgG |
41272-6 | Dog dander+Dog epithelium IgE Ab RAST class in Serum | Dog dander+Dog epithelium Ab.IgE.RAST class |
6099-6 | Dog epithelium IgE Ab [Units/volume] in Serum | Dog epithelium Ab.IgE |
15686-9 | Dog epithelium IgE Ab RAST class in Serum | Dog epithelium Ab.IgE.RAST class |
7285-0 | Dog epithelium IgG Ab [Units/volume] in Serum | Dog epithelium Ab.IgG |
7286-8 | Dog epithelium triggered histamine release [Units/volume] in Blood | Dog epithelium basophil bound Ab |
48229-9 | Dog epithelium triggered leukotriene release [Mass/volume] by Leukocytes | Dog epithelium leukotriene release |
19738-4 | Dog serum albumin IgE Ab [Units/volume] in Serum | Dog serum albumin Ab.IgE |
25395-5 | Dog serum albumin IgE Ab RAST class in Serum | Dog serum albumin Ab.IgE.RAST class |
7288-4 | Dogwood pollen IgE Ab [Units/volume] in Serum | Dogwood pollen Ab.IgE |
7792-5 | Dohle body [Presence] in Blood by Light microscopy | Dohle body |
12606-0 | Dolichol [Mass/volume] in Serum or Plasma | Dolichol |
21249-8 | Dolichol [Mass/volume] in Urine | Dolichol |
39544-2 | Yellow Hornet IgE Ab [Ratio] in Serum | Dolichovespula arenaria Ab.IgE |
6288-5 | Yellow Hornet IgE Ab [Units/volume] in Serum | Dolichovespula arenaria Ab.IgE |
15783-4 | Yellow Hornet IgE Ab RAST class in Serum | Dolichovespula arenaria Ab.IgE.RAST class |
49740-4 | Yellow Hornet IgG Ab [Mass/volume] in Serum | Dolichovespula arenaria Ab.IgG |
6739-7 | Yellow Hornet IgG Ab [Units/volume] in Serum | Dolichovespula arenaria Ab.IgG |
41192-6 | Yellow Hornet IgG4 Ab [Presence] in Serum | Dolichovespula arenaria Ab.IgG4 |
6280-2 | Whitefaced Hornet IgE Ab [Units/volume] in Serum | Dolichovespula maculata Ab.IgE |
15782-6 | Whitefaced Hornet IgE Ab RAST class in Serum | Dolichovespula maculata Ab.IgE.RAST class |
49745-3 | Whitefaced Hornet IgG Ab [Mass/volume] in Serum | Dolichovespula maculata Ab.IgG |
7417-9 | Whitefaced Hornet IgG Ab [Units/volume] in Serum | Dolichovespula maculata Ab.IgG |
44315-0 | Whitefaced Hornet IgG Ab RAST class in Serum | Dolichovespula maculata Ab.IgG.RAST class |
41193-4 | Whitefaced Hornet IgG4 Ab [Presence] in Serum | Dolichovespula maculata Ab.IgG4 |
44658-3 | None | Dominant nodule.additional dimension 1 |
44659-1 | None | Dominant nodule.additional dimension 2 |
44657-5 | None | Dominant nodule.max.dimension |
51418-2 | Domperidone [Molecules/volume] in Body fluid | Domperidone |
51442-2 | Domperidone [Molecules/volume] in Serum or Plasma | Domperidone |
28368-9 | None | Don't have to keep fighting |
28367-1 | None | Don't want high technology to keep me alive |
53948-6 | Donated egg [Presence] | Donated egg |
18286-5 | Donath Landsteiner Ab [Presence] in Blood | Donath Landsteiner Ab |
18287-3 | Donath Landsteiner Ab [Presence] in Serum & RBC from control | Donath Landsteiner Ab |
18288-1 | Donath Landsteiner Ab [Titer] in Serum & RBC from control | Donath Landsteiner Ab |
48817-1 | Donath Landsteiner Ab [Titer] in Serum from control | Donath Landsteiner Ab |
51979-3 | Donepezil [Mass/volume] in Serum or Plasma | Donepezil |
3143-5 | None | Donor relation to patient |
14703-3 | Dopamine [Molecules/volume] in Serum or Plasma | Dopamine |
15058-1 | Dopamine [Molecules/volume] in Urine | Dopamine |
15059-9 | Dopamine [Molecules/time] in 24 hour Urine | Dopamine |
2216-0 | Dopamine [Mass/volume] in Serum or Plasma | Dopamine |
2217-8 | Dopamine [Mass/volume] in Urine | Dopamine |
2218-6 | Dopamine [Mass/time] in 24 hour Urine | Dopamine |
25906-9 | Dopamine [Molecules/volume] in 24 hour Urine | Dopamine |
27212-0 | Dopamine [Mass/volume] in 24 hour Urine | Dopamine |
2219-4 | Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma | Dopamine beta-hydroxylase |
13733-1 | Dopamine/Creatinine [Mass ratio] in Urine | Dopamine/Creatinine |
24524-1 | Dopamine/Creatinine [Molecular ratio] in Urine | Dopamine/Creatinine |
33873-1 | Dopamine/Creatinine [Molecular ratio] in unspecified time Urine | Dopamine/Creatinine |
44316-8 | Dopamine/Creatinine [Mass ratio] in 24 hour Urine | Dopamine/Creatinine |
44918-1 | Dopamine/Creatinine [Molecular ratio] in 24 hour Urine | Dopamine/Creatinine |
27443-1 | Dopamine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | Dopamine^1H post XXX challenge |
27348-2 | Dopamine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | Dopamine^2H post XXX challenge |
13432-0 | Dopamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | Dopamine^2nd specimen post XXX challenge |
16784-1 | Dopamine [Mass/volume] in Urine --2nd specimen post XXX challenge | Dopamine^2nd specimen post XXX challenge |
27363-1 | Dopamine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | Dopamine^3H post XXX challenge |
13433-8 | Dopamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | Dopamine^3rd specimen post XXX challenge |
16785-8 | Dopamine [Mass/volume] in Urine --3rd specimen post XXX challenge | Dopamine^3rd specimen post XXX challenge |
27380-5 | Dopamine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge | Dopamine^4H post XXX challenge |
13434-6 | Dopamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | Dopamine^4th specimen post XXX challenge |
16786-6 | Dopamine [Mass/volume] in Urine --4th specimen post XXX challenge | Dopamine^4th specimen post XXX challenge |
13435-3 | Dopamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | Dopamine^5th specimen post XXX challenge |
16787-4 | Dopamine [Mass/volume] in Urine --5th specimen post XXX challenge | Dopamine^5th specimen post XXX challenge |
13436-1 | Dopamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | Dopamine^6th specimen post XXX challenge |
16788-2 | Dopamine [Mass/volume] in Urine --6th specimen post XXX challenge | Dopamine^6th specimen post XXX challenge |
13437-9 | Dopamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Dopamine^7th specimen post XXX challenge |
16789-0 | Dopamine [Mass/volume] in Urine --7th specimen post XXX challenge | Dopamine^7th specimen post XXX challenge |
34068-7 | None | Dosage & administration section |
43678-2 | None | Dosage forms and strengths section |
52809-1 | None | Dose form |
30973-2 | None | Dose number |
29652-5 | Dothiepin [Mass/volume] in Serum or Plasma | Dothiepin |
29653-3 | Dothiepin [Molecules/volume] in Serum or Plasma | Dothiepin |
35120-5 | Dothiepin sulfoxide [Mass/volume] in Serum or Plasma | Dothiepin sulfoxide |
45422-3 | None | Down's syndrome |
10985-0 | Doxapram [Mass/volume] in Serum or Plasma | Doxapram |
14704-1 | Doxepin [Presence] in Gastric fluid | Doxepin |
14705-8 | Doxepin [Molecules/volume] in Serum or Plasma | Doxepin |
14706-6 | Doxepin [Molecules/volume] in Urine | Doxepin |
16115-8 | Doxepin [Mass/mass] in Tissue | Doxepin |
29410-8 | Doxepin [Mass/volume] in Gastric fluid | Doxepin |
35609-7 | Doxepin [Mass/volume] in Serum or Plasma by Screen method | Doxepin |
3578-2 | Doxepin [Presence] in Serum or Plasma | Doxepin |
3579-0 | Doxepin [Mass/volume] in Serum or Plasma | Doxepin |
3580-8 | Doxepin [Presence] in Urine | Doxepin |
3581-6 | Doxepin [Mass/volume] in Urine | Doxepin |
40629-8 | Doxepin [Presence] in Unspecified specimen | Doxepin |
4230-9 | Doxepin [Mass] of Dose | Doxepin |
47104-5 | Doxepin [Molecules/volume] in Gastric fluid | Doxepin |
43122-1 | Doxepin & Nordoxepin panel [Mass/volume] in Serum or Plasma | Doxepin & Nordoxepin panel |
16790-8 | None | Doxepin+Desmethyldoxepin |
19247-6 | Doxepin+Metabolites [Mass/volume] in Urine | Doxepin+Metabolites |
3583-2 | Doxepin+Metabolites [Mass/volume] in Serum or Plasma | Doxepin+Metabolites |
10537-9 | None | Doxepin+Nordoxepin |
14707-4 | Doxepin+Nordoxepin [Molecules/volume] in Serum or Plasma | Doxepin+Nordoxepin |
3582-4 | Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | Doxepin+Nordoxepin |
3584-0 | Doxepin [Mass/volume] in Serum or Plasma --trough | Doxepin^trough |
13624-2 | Doxorubicin [Mass/volume] in Serum or Plasma | Doxorubicin |
10986-8 | Doxycycline [Mass/volume] in Serum or Plasma | Doxycycline |
18917-5 | Doxycycline [Susceptibility] | Doxycycline |
20379-4 | Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria | Doxycycline |
21250-6 | Doxycycline [Mass/volume] in Unspecified specimen | Doxycycline |
224-6 | Doxycycline [Susceptibility] by Minimum lethal concentration (MLC) | Doxycycline |
225-3 | Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Doxycycline |
226-1 | Doxycycline [Susceptibility] by Disk diffusion (KB) | Doxycycline |
227-9 | Doxycycline [Susceptibility] by Serum bactericidal titer | Doxycycline |
23623-2 | None | Doxycycline |
26902-7 | Doxycycline [Units/volume] in Unspecified specimen | Doxycycline |
7008-6 | Doxycycline [Susceptibility] by Gradient strip (E-test) | Doxycycline |
25223-9 | Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Doxycycline 30.0 ug/mL |
16791-6 | Doxylamine [Mass/volume] in Serum or Plasma | Doxylamine |
16792-4 | Doxylamine [Mass/volume] in Urine | Doxylamine |
3585-7 | Doxylamine [Presence] in Serum or Plasma | Doxylamine |
3586-5 | Doxylamine [Presence] in Urine | Doxylamine |
4231-7 | Doxylamine [Mass] of Dose | Doxylamine |
28883-7 | None | Doz.inside |
28906-6 | None | Doz.inside |
28934-8 | None | Doz.inside |
28961-1 | None | Doz.inside |
28884-5 | None | Doz.outside |
28907-4 | None | Doz.outside |
28935-5 | None | Doz.outside |
28962-9 | None | Doz.outside |
18034-9 | None | dP/dT (1 M/S to 3 M/S).systole |
18035-6 | None | dP/dT (1M/S to 3 M/S) |
45284-7 | DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DPYD gene mutation analysis |
39116-9 | None | Drainage amount |
39115-1 | None | Drainage description |
28409-1 | None | Dressing |
39121-9 | None | Dressing |
28093-3 | None | Dressing &or grooming deficit |
45600-4 | None | Dressing - self-performance |
45601-2 | None | Dressing - support provided |
53245-7 | None | Driver license image attachment |
16144-8 | Droperidol [Presence] in Serum or Plasma | Droperidol |
34074-5 | None | Drug &or laboratory test interactions section |
42831-8 | None | Drug abuse |
42227-9 | None | Drug abuse and dependence section |
53975-9 | Drug crystals [Presence] in Urine sediment by Light microscopy | Drug crystals |
51964-5 | Drug efficacy analysis overall interpretation [interpretation] in Blood or Tissue by Molecular genetics method | Drug efficacy analysis overall interpretation |
51961-1 | Drug efficacy marker interpretation [interpretation] in Blood or Tissue Qualitative by Molecular genetics method | Drug efficacy marker interpretation |
34073-7 | None | Drug interactions section |
52570-9 | None | Drug list is complete |
51971-0 | Drug metabolism analysis overall interpretation [interpretation] in Blood or Tissue by Molecular genetics method | Drug metabolism analysis overall interpretation |
53040-2 | Drug metabolism marker interpretation [interpretation] in Blood or Tissue by Molecular genetics method | Drug metabolism marker interpretation |
39245-6 | None | Drug or alcohol abuse counselled |
12286-1 | Drugs identified in Urine by Screen method | Drugs identified |
12287-9 | Drugs identified in Gastric fluid by Screen method | Drugs identified |
12289-5 | Drugs identified in Vitreous fluid by Screen method | Drugs identified |
15401-3 | Drugs identified in Blood by Screen method | Drugs identified |
16793-2 | Drugs identified in Unknown substance by Screen method | Drugs identified |
20785-2 | Drugs identified in Serum or Plasma by Screen method | Drugs identified |
20786-0 | Drugs identified in Tissue by Screen method | Drugs identified |
20787-8 | Drugs identified in Unspecified specimen by Screen method | Drugs identified |
27034-8 | Drugs identified in Hair by Screen method | Drugs identified |
27208-8 | Drugs identified in Stool by Screen method | Drugs identified |
32797-3 | Drugs identified in Meconium by Screen method | Drugs identified |
34601-5 | Drugs identified in Body fluid | Drugs identified |
40464-0 | Drugs identified in Urine by Confirm method | Drugs identified |
40585-2 | Drugs identified in Unspecified specimen by Confirm method | Drugs identified |
41270-0 | Drugs identified in Urine | Drugs identified |
42326-9 | Drugs identified in Mother's Milk by Screen method | Drugs identified |
24349-3 | Drugs of abuse 5 panel in Urine | Drugs of abuse 5 panel |
51782-1 | Drugs of abuse 9 panel in Urine | Drugs of abuse 9 panel |
49046-6 | Drugs of abuse panel in Meconium | Drugs of abuse panel |
28382-0 | None | Dry mouth |
23030-0 | Duck enteritis virus [Presence] in Tissue by Electron microscopy | Duck enteritis virus |
20788-6 | Duck enteritis virus Ab [Presence] in Serum by Neutralization test | Duck enteritis virus Ab |
22254-7 | Duck enteritis virus Ab [Presence] in Serum | Duck enteritis virus Ab |
43328-4 | Duck enteritis virus Ab [Presence] in Serum by Immunofluorescence | Duck enteritis virus Ab |
20852-0 | Duck enteritis virus Ag [Units/mass] in Tissue Qualitative by Immunofluorescence | Duck enteritis virus Ag |
23031-8 | Duck enteritis virus Ag [Presence] in Unspecified specimen by Neutralization test | Duck enteritis virus Ag |
23032-6 | Duck enteritis virus Ag [Presence] in Unspecified specimen by Agglutination | Duck enteritis virus Ag |
31802-2 | Duck enteritis virus Ag [Presence] in Unspecified specimen | Duck enteritis virus Ag |
6100-2 | Duck feather IgE Ab [Units/volume] in Serum | Duck feather Ab.IgE |
15687-7 | Duck feather IgE Ab RAST class in Serum | Duck feather Ab.IgE.RAST class |
7289-2 | Duck feather IgG Ab [Units/volume] in Serum | Duck feather Ab.IgG |
23033-4 | Duck hepatitis virus 1 Ab [Presence] in Serum by Neutralization test | Duck hepatitis virus 1 Ab |
23034-2 | Duck hepatitis virus 1 Ab [Presence] in Serum | Duck hepatitis virus 1 Ab |
23035-9 | Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen by Neutralization test | Duck hepatitis virus 1 Ag |
31803-0 | Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen | Duck hepatitis virus 1 Ag |
23036-7 | Duck hepatitis virus 2 Ab [Presence] in Serum | Duck hepatitis virus 2 Ab |
23037-5 | Duck hepatitis virus 2 Ab [Presence] in Serum by Neutralization test | Duck hepatitis virus 2 Ab |
23038-3 | Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen by Neutralization test | Duck hepatitis virus 2 Ag |
31804-8 | Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen | Duck hepatitis virus 2 Ag |
23039-1 | Duck hepatitis virus 3 Ab [Presence] in Serum | Duck hepatitis virus 3 Ab |
23040-9 | Duck hepatitis virus 3 Ab [Presence] in Serum by Neutralization test | Duck hepatitis virus 3 Ab |
23041-7 | Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen by Immunofluorescence | Duck hepatitis virus 3 Ag |
31805-5 | Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen | Duck hepatitis virus 3 Ag |
6101-0 | Duck meat IgE Ab [Units/volume] in Serum | Duck meat Ab.IgE |
25396-3 | Duck meat IgE Ab RAST class in Serum | Duck meat Ab.IgE.RAST class |
13309-0 | Duffy group Ag [Type] on Red Blood Cells | Duffy group Ag |
46227-5 | Duloxetine [Mass/volume] in Serum or Plasma | Duloxetine |
21960-0 | None | Duration |
10572-6 | None | Duration^post ejaculation |
6102-8 | None | Dust profile Ab.IgE |
21969-1 | None | Dx &or stage |
21861-0 | None | Dx confirmed by |
28094-1 | None | Dying process |
3587-3 | Dyphylline [Mass/volume] in Serum or Plasma | Dyphylline |
4232-5 | Dyphylline [Mass] of Dose | Dyphylline |
32653-8 | DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DYS gene mutation analysis |
46992-4 | DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DYS gene mutation analysis |
43745-9 | DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | DYS gene mutations tested for |
51589-0 | Dyserythropoiesis [Presence] in Blood by Light microscopy | Dyserythropoiesis |
53856-1 | DYSF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DYSF gene mutation analysis |
35124-7 | Dysferlin [Presence] in Leukocytes | Dysferlin |
28095-8 | None | Dysfunctional grieving |
34489-5 | DYT1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method | DYT1 gene deletion |
34495-2 | DYT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Narrative | DYT1 gene mutation analysis |
38411-5 | DYT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | DYT1 gene mutation analysis |